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1. INTRODUCTION
Humans have developed systems for detecting changes in the external environment. The known 
senses are: sight (ophthalmoception), taste (gustaoception), smell (olfacception) and touch 
(tactioception). We perceive up to 80 percent of all impressions by means of our sight so by far 
the most important organs of sense are our eyes. If other senses stop working, it’s the eyes that 
best protect us from danger. Vision occurs when light is processed by the eye, and then 
interpreted by the brain.
1.1. ANATOMY OF THE EYE
First transparent eye surface responsible for vision is cornea.
The cornea is a transparent avascular tissue with a smooth, convex outer surface and concave 
inner surface, of which the main function is optical. The axial thickness of the cornea ranges 
from 0.50 to 0.52 millimeters (mm), with 5 histological layers. 1-3
The epithelium, the outermost layer (1st layer), provides a smooth refractive surface and serves 
as a barrier against microorganisms. Bowman’s layer (2nd layer) is a narrow, acellular, 
homogeneous zone with uncertain functions. The resistance of the cornea is due to the 
collagenous components of the stroma (3rd layer), accounting for 90% of the corneal thickness. 4-6
The endothelium and its basement membrane (Descemet’s membrane, the 4th layer) are 
responsible for the relative dehydration necessary for corneal clarity via an active sodium po-
tassium – adenosine triphosphatase pump. 7
Cornea, anterior chamber and lens refract light, with the cornea accounting for approximately 
two-thirds of the eye’s total optical power. In humans, the refractive power of the cornea is 
approximately 43 diopters (D). 8
When the light passes through the cornea, it goes through the pupil that is controlled by the iris 
and then it passes through flexible crystaline lens that focuses light on the retina. On the way 
to the retina light also passes through the interior of the eye that is filled with gel fluid called 
corpus vitreous. Retina converts the light into nerve impulses which are carried with neurons 
to the vision centers in the brain and there they get interpreted so we can see.
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FIGURE 1. Anatomy of the eye
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1.2. ASTIGMATISM
1.2.1. HISTORICAL BACKGROUND
Sir Isaac Newton was one of the first scientists who considered question of astigmatism in the 
late 1727. In 1801, the scientist Thomas Young continued investigation of astigmatism in details 
and was the first one to report it. 9
In 1827 Cambridge astronomer Airy first corrected astigmatism with a cylindrical lens. However, 
the invention of the keratometer by Helmholtz in 1856 and the work of Donders in 1864, “Astigmatism 
and Cylindrical Lenses” brought astigmatism on the map as something of importance. Donders 
was probably the first to include cylinder lenses in the trial case for refraction. In 1869 Snellen 
made early attempts in surgical correction of astigmatism. His theories and theories of Bates 
(1891), Luciola (1893) and Dognoff (1895) were confirmed by Lans in 1897. 10
1.2.2. DEFINITION AND CLASSIFICATION OF ASTIGMATISM
Astigmatism is a type of refractive error in which the eye does not focus light evenly on the retina. 11
When the light is not evenly focused on the retina picture that we are seeing is going to be 
blurred and vision is poor. Another common symptom is the streak phenomena of rays around 
point sources of light, most noticeable in dark environments. If the amount of astigmatism is 
high, it may induce letters to have shadows or smear around it and in very high amounts, it may 
cause diplopia.
FIGURE 2. Astigmatism image
Illustration courtesy by © David Allamby 2015
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FIGURE 3. Cross section of astigmatic eye
Illustration courtesy Ciba Vision®
The total amount of astigmatism is entirely dependent upon the anatomy of the eye. All seg-
ments of the physical optical media, including the cornea, the lens, and even occasionally the 
retina, can contribute toward the development of astigmatism, and each should be examined 
to understand its role in relation to the disorder.
The prevalence of astigmatism greater than 1 D in the general population is reported to be 
between 32% and 56%. 12, 13
It is known that higher degrees of astigmatism are more common in eyes with a higher level of 
ametropia. 14-16
In most cases, astigmatism is a result of the corneal shape (and sometimes the lens) that is 
present since birth. Normally, the surface of the cornea is rounded, however in astigmatism the 
cornea is shaped more oval. In eyes without astigmatism, the cornea and lens have a more or 
less similar curvature in all directions. This allows light to be focused to a single point on the 
retina.
In astigmatism the cornea is elliptically shaped. There is a long meridian and a short meridian. 
These two meridians generally have a constant curvature and are generally perpendicular to 
each other (regular astigmatism). Irregular astigmatism may have more than two meridians of 
focus and they may not be 90° apart. A point of light, therefore, going through an astigmatic 
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cornea will have two points of focus, instead of one nice sharp image on the retina. This will 
cause the person to have blurry vision. What the blur looks like will depend upon the amount 
and the direction of the astigmatism.
Lenticular astigmatism is similar to corneal astigmatism, except it exists in the lens rather than 
the cornea. The lens may have variations in its curvature rather than having a perfect curve, 
causing images to reach the back of the eye (the retina) imperfectly. Most people with lenticular 
astigmatism have a normal-shaped cornea and the defect is only in the curvature of the lens.
Astigmatism could be also related with retinal structure. Directional variability in photoreceptor 
arrangement was also proposed as a source of astigmatism. 17
In other words, functional retinal elements may be more abundant or thicker in one axis than 
the other. 18
In 1995 a “tilted” retina was simulated and it was observed to manifest as some degree of 
cylindrical error. 19
This could be the result of unequal lengthening of the sclera in different meridians during axial 
growth. 20
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FIGURE 4. Image of normal and cornea with astigmatism
Source: National Eye Institute
There are different types of astigmatism. Depending on the axis of the principal meridian 
astigmatism can be:
•	 Regular	astigmatism	–	principal	meridians	are	perpendicular.
•	 With-the-rule	astigmatism	–	the	vertical	meridian	is	steepest	(a	rugby	ball	or	American	
football lying on its side). 21
•	 Against-the-rule	astigmatism	–	the	horizontal	meridian	is	steepest	(a	rugby	ball	or	Amer-
ican football standing on its end). 21
•	 Oblique	astigmatism	–	the	steepest	curve	lies	in	between	120	and	150	degrees	and	30	
and 60 degrees. 21
•	 Irregular	astigmatism	–	principal	meridians	are	not	perpendicular. 21
In with-the-rule astigmatism, a minus cylinder is placed in the horizontal axis to correct the 
refractive error (or a plus cylinder in the vertical axis). Adding a minus cylinder in the horizontal 
axis makes the horizontal axis “steeper” (or better: makes the vertical axis “less steep”) which 
makes both axes equally “steep”. In against-the-rule astigmatism, a plus cylinder is added in 
the horizontal axis (or a minus cylinder in the vertical axis).
Axis is always recorded as an angle in degrees, between 0 and 180 degrees in a counter-clock-
wise direction. Both 0 and 180 degrees lie on a horizontal line at the level of the center of the 
pupil, and as seen by an observer, 0 lies on the right of both the eyes.
With accommodation relaxed, astigmatism can be:
•	 Simple	astigmatism 21
•	 Simple	hyperopic	astigmatism	–	first	focal	line	is	on	retina,	while	the	second	is	located	
behind the retina.
•	 Simple	myopic	astigmatism	–	first	focal	line	is	in	front	of	the	retina,	while	the	second	is	on	
the retina.
•	 Compound	astigmatism 21
•	 Compound	hyperopic	astigmatism	–	both	focal	lines	are	located	behind	the	retina.
•	 Compound	myopic	astigmatism	–	both	focal	lines	are	located	in	front	of	the	retina.
•	 Mixed	astigmatism	–	focal	lines	are	on	both	sides	of	the	retina	(straddling	the	retina). 21
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There are certain eye conditions which are associated with astigmatism. Astigmatism can result 
from anomalies in corneal structure (e.g. corneal ecstasies and dystrophies). Some of the 
disorders are present from birth and some others develop throughout the life. The most common 
of these conditions is keratoconus. The prevalence of astigmatism is especially high in Down 
syndrome. 22
In addition, astigmatism can result from an injury, scar or operation to the eye, particularly if the 
corneal surface is damaged. It can also result from anything pressing persistently on the surface 
of the cornea (such as a large lump on the eyelid) which pushes it out of shape.
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1.2.3. ABERRATIONS OF THE EYE
Eye is not a perfect optical system; however, its imperfections cancel each other out through 
certain parts and in some other cases are adding to each other. An optical aberration is an 
imperfection in the image formation of an optical system. To understand that optical system we 
use Zernike polynomial expansion. 23-25
Aberrations are alterations of the optical surfaces of the eye that lead to deviations in the light 
entering the eye, 26 causing a decline in visual quality and a loss of contrast sensitivity. 27
Low order aberrations include myopia (positive defocus), hyperopia (negative defocus), and 
regular astigmatism. Other lower-order aberrations are non-visually significant aberrations known 
as first order aberrations, such as prisms and zero-order aberrations (piston). Low order 
aberrations account for approximately 90% of the overall wave aberrations in the eye. 28, 29
Higher-order aberrations comprise many varieties of aberrations. Some of them have names 
such as spherical aberration, coma and trefoil, but many more of them are identified only by 
mathematical expressions (Zernike polynomials). They make up about 10% of the total number 
of aberrations in an eye.
Spherical aberration results in halos around point images. Spherical aberration is defined as a 
second order aberration. Spherical aberration exacerbates myopia in low light (night myopia). 
In brighter conditions, the pupil constricts, blocking the more peripheral rays and minimizing the 
effect of spherical aberration. As the pupil enlarges, more peripheral rays enter the eye and the 
focus shifts anteriorly, making the patient slightly more myopic in low-light conditions. 28
Coma causes light to be smeared like the tail of a comet in the night sky. Coma is defined as 
third order aberration and we have horizontal and vertical coma (axial and off-axis). Symptom 
of coma is usually double vision.
Trefoil (or elliptical coma) causes a point of light to smear in three dimensions and produces 
less degradation in image quality compared with coma. 29
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FIGURE 5. Image of Zernike polynomials
This chart reveals more common shapes of aberrations created when a wavefront of light passes 
through eyes with imperfect vision. A theoretically perfect eye (top) is represented by  
an aberration-free flat plane known, for reference, as piston. (Image: Alcon Inc.)
Today, it is possible to objectively evaluate the eye’s optical quality in clinical practice using 
aberrometers, usually based on the Hartmann-Shack wavefront sensor 26, 30 or laser ray 
tracing 31, 32 and newer devices based on the double-pass technique. 33, 34
Higher amounts of aberrations are primarily connected with irregular astigmatism.
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1.3. ASTIGMATISM DIAGNOSTICS
1.3.1. KERATOMETERS
Keratometry is the measurement of the anterior corneal curvature and is traditionally performed 
with a manual keratometer. This device was developed by von Helmholtz in 1880. It is an instru-
ment that gives 2 corneal curvature values (maximum and minimum) 90 degrees apart.
The two basic keratometers are the Helmholtz type and the Javal-Schiotz type. Both use the 
relationship between object size, image size and distance to calculate corneal curvature. The 
former is the more familiar to most ophthalmologists. It is a one-position device that uses 
adjustable image size and consists of aligning plus sign and minus sign mires. The latter is a 
two-position instrument that uses adjustable object size and requires alignment of a red square 
and green staircase design. Keratometers measure the size of an image reflected from two 
paracentral points on the cornea. The instrument contains doubling prisms to stabilize the image 
allowing more accurate focusing. The anterior corneal curvature is then obtained from the convex 
mirror formula and corneal power is calculated empirically using Snell’s law of refraction with 
simplified optics. The keratometer measures the anterior corneal surface but uses an assumed 
index of refraction (1.3375 rather than the actual 1.376) to account for the small contribution 
from the posterior corneal surface, the corneal thickness, and also to allow 45 D to equal 7.5 
mm radius of curvature (K (diopters) = 337.5/r). These simplifications and assumptions create 
a number of limitations. The keratometer only measures a small region of the cornea (i.e., 
2 points at the 3-4 mm zone), and this measured region is different for corneas of different powers. 
No information is provided about the cornea central or peripheral to these points. Furthermore, 
the keratometer assumes that the cornea has a symmetric spherocylindrical shape with a major 
and minor axis separated by 90 degrees. It also does not account for spherical aberration, and 
it is susceptible to focusing and misalignment errors. Finally, distortion of the mires precludes 
accurate measurement of irregular corneas and cannot be quantified. 35
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1.3.2. CORNEAL TOPOGRAPHY AND TOMOGRAPHY
Corneal topography is used to characterize the shape of the cornea, similar to how one would 
characterize a mountain using a topographic map. Originally, corneal topography was only used 
to describe the anterior surface of the cornea. Devices now are able to characterize both the 
anterior and posterior corneal surfaces, creating a three-dimensional map (corneal tomography). 
Advances in digital photography and computer processing have vastly increased the utility of 
corneal topography. 36
The first advancement in assessing the shape of the anterior corneal surface was made in the 
late 1800s with the development of the Placido disc. 36
This technique characterizes the corneal surface by assessing the reflection of a set of concentric 
rings of the anterior corneal surface. As the image from the Placido disc is projected on the 
cornea, some of the light is reflected off the tear film-air interface like a mirror. The pattern of 
light reflection reveals the shape of the anterior surface of the cornea. 36
A second technique for corneal topographic assessment is the scanning slit technique (e.g., 
Orbscan). This method uses rapidly scanning projected slit beams of light and a camera to 
capture the reflected beams to create a map of the anterior and posterior corneal surface. A 
third technique, known as Scheimpflug imaging, uses a rotating camera to photograph corneal 
cross-sections illuminated by slit beams at different angles (e.g., Pentacam). This method 
corrects for the non-planar shape of the cornea and, thus, allows greater accuracy and resolution 
in creating a 3-D map of the cornea. 37-39
The Oculus Pentacam utilizes Scheimpflug technology to create topographic reports. The reports 
contain numerous informations, and samples of the overview report and the 4 maps report are 
provided below. Specifically, the overview report provides the Scheimpflug image, which is a 
cross-sectional image showing the cornea, anterior chamber, iris and lens. Three-D representation 
of the patient’s corneal shape is also provided. The density of the cornea is evaluated using 
densitometry, which is an objective measurement of light scatter in the cornea. Any densitometry 
value less than ~30 is considered normal; thus, a condition resulting in decreased corneal clarity 
(e.g., corneal edema) will increase the densitometry value. There is also a convenient summary 
of the keratometry, pachymetry, and other numeric measurements in this report. A pachymetry 
color map indicates corneal thickness.
12
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FIGURE 6. Pentacam image of cornea – with the rule astigmatism
FIGURE 7. Pentacam image of cornea – oblique astigmatism
FIGURE 8. Pentacam image of cornea – against the rule astigmatism
FIGURE 9. Pentacam image of cornea – irregular astigmatism
13
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Pentacam report named “4 maps refractive” provides a summary of keratometry, pachymetry 
with map, and numeric measurements. Pentacam report includes the axial curvature map, also 
known as a sagittal map, depicts the curvature of the anterior corneal surface in dioptric values 
for each point. The color scale represents the power in diopters at each particular point. Warmer 
colors represent steeper corneal curvature while cooler colors represent flatter areas. Anterior 
float and posterior float images, which are elevation maps, are generated on the Pentacam 
report. Instead of displaying the refractive power of the cornea, elevation maps display the shape 
of the cornea by comparing it to a computer-generated best-fit sphere (i.e., a perfect sphere 
that best approximates the corneal shape on average). Posterior float, similar to the anterior 
float, shows the shape of the posterior cornea compared to a best-fit sphere. For the elevation 
maps (anterior and posterior float), warmer colors denote where the cornea is elevated above 
the best fit sphere and cooler colors denote where the cornea is depressed below the best fit 
sphere. A pachymetry map is a color map that indicates corneal thickness; cooler colors are 
thicker and warmer colors are thinner. 40, 41, 42
The main uses of corneal topography include pre-operative evaluation to rule out certain corneal 
abnormalities and postoperative evaluation to monitor the surgeon’s and laser’s performance. 
Moreover, corneal topographic analysis has become the standard of care in the pre-operative 
evaluation of all refractive surgical patients because of its ability to diagnose subclinical ectatic 
disorders. 40, 41, 42
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1.4. NON SURGICAL TREATMENT OF ASTIGMATISM
1.4.1. PRESCRIPTION SPECTACLES (EYEGLASSES)
Spectacles are the simplest way of correction. In general, lenses are made from three materials: 
plastic, glass, and polycarbonate.
The spectacle lenses for astigmatism correction have a toric or cylindrical surface in order to 
give a single focal point in the retina. It adjusts the direction of the incoming light rays, correcting 
the uneven curve of the cornea. The thickness of the lens is not the same across its surface. 
This difference in thickness is increased due to the strength of the astigmatism.
Spectacles are a choice of correction for people with regular astigmatism. They will contain a 
cylindrical lens prescription for the astigmatism in a specific meridian of the lens which designates 
the axis of the lens power. Higher degrees of astigmatism and more complex corrections (i.e. 
very high myopic or hyperopic astigmatism and mixed astigmatism) cannot accomplish optimal 
quality of vision with spectacle correction. In addition, irregular astigmatism cannot be corrected 
by a lens of the glasses. 43, 44
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1.4.2. CONTACT LENSES
1.4.2.1. SOFT CONTACT LENSES
Contact lenses sit right on the surface of the eye. Many different types of contact lenses are 
available on the market.
Soft contact lenses conform to the shape of the eye. They come in spherical and toric version. 
Their toric version can be used for astigmatism correction. They are readily available in several 
fitting designs. The astigmatic correction can be on the front or the back surface of the lens. 
Toric lenses typically have a mark to note the 6-o’clock position.
Contact lenses often provide better vision than do spectacles by masking irregular astigmatism 
(high orders of aberration). For mild to moderate irregularities, soft spherical, soft toric or custom 
soft toric lenses are used. Large irregularities typically require rigid gas permeable (RGP) contact 
lenses to mask abnormal surface; the anterior surface of the contact lens creates a new optic 
surface, and the tear film corrects the corneal irregularities.
1.4.2.2. RIGID GAS-PERMEABLE CONTACT LENSES
Rigid gas permeable contact lenses maintain their regular shape while on the cornea, and offer 
an effective way to compensate for the cornea’s irregular shape and improve the vision of 
persons with astigmatism and other refractive errors. Parameters of RGP lenses are custom 
made for each patient. They come in spherical and toric version. Bi-toric designs are the most 
popular toric design in RGP contact lens practice, and represent the best choice if corneal 
toricity is less than or exceeds refractive astigmatism.
Some specialized RGP lenses have been developed specifically for keratoconus. Most provide 
a steep central posterior curve to vault over the cone and flatter peripheral curves to approximate 
the more normal peripheral curvature.
An alternative approach is to use hybrid contact lens that comprises a rigid center and a soft 
skirt. The hybrid lens theoretically provides the good vision of an RGP lens and the comfort of 
a soft lens.
Piggyback lens systems involve the fitting of a soft contact lens with an RGP lens fitted over it. 
This system may allow comfort benefits similar to those offered by hybrid lenses, as well as a 
greater choice of contact lens parameters.
Gas-Permeable Scleral Contact lenses have 2 primary indications: (1) correcting abnormal 
regular and irregular astigmatism in eyes that preclude the use of rigid corneal contact lenses, 
and (2) managing ocular surface diseases that benefit from the constant presence of a protective, 
lubricating layer of oxygenated artificial tears. 45, 46
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1.5. SURGICAL TREATMENT OF ASTIGMATISM
Surgical correction of astigmatism takes place chiefly in the corneal tissue, by the means of 
corneal incisional or corneal refractive surgery, or it is compensated with toric intraocular lenses. 
As mentioned before astigmatism also can be corneal or lenticular. Even if the astigmatism is 
lenticular in young population can be compensated with corneal refractive surgery.
1.5.1. INCISIONAL SURGERY
1.5.1.1. RADIAL KERATOTOMY
Radial keratotomy (RK) is now largely considered an obsolete procedure, but it did play an 
important role in the history of refractive surgery. 47
Radial keratotomy (RK) as a refractive surgical procedure to correct myopia (nearsightedness) 
was finally completed and developed in 1974, by Svyatoslav Fyodorov, a Russian ophthalmologist.
In RK, incisions are made with a diamond knife. Incisions that penetrate only the superficial 
corneal stroma are less effective than those reaching deep into the cornea, and consequently, 
incisions are made quite deep. 48
Radial corneal incisions severed collagen fibrils in the corneal stroma. This produced a wound 
gape with midperipheral bulging of the cornea, compensatory central corneal flattening, and 
decrased refractive power. The design of the diamond-blade knife (angle and sharpness of 
cutting edge, width of blade, and design of footplate) influenced both the depth and the contour 
of incisions. The footplates reduced the risk of penetration and stabilized the blade. The guard 
on the front of the blade prevented inadvertent entry into the central optical zone. The length of 
the knife blade and the associated depth of the incisions were set according to the corneal 
thickness, which was usually measured with an ultrasonic pachymeter. The ideal depth of RK 
incisions was 85-90% of the corneal thickness. 49
Potential serious complications include loss of best-corrected visual acuity, perforation of the 
cornea, infection and rupture of the globe. Some of the major concerns with this procedure 
relate to the significant corneal instability induced by the surgery, including diurnal fluctuation 
of refractive error, overcorrection, hyperopic shift and potential rupture of the globe with blunt 
trauma. 50
Although ophthalmologists do not initially perceive radial keratotomy as a means for correcting 
astigmatism, it follows that if it selectively flattens the cornea more in some meridians, the 
ophthalmologist are effectively correcting astigmatism. Although the predictability is slightly less 
in correcting astigmatism than that for correction of myopia, there is an opinion that it is still 
rather good option for astigmatism treatment. 51
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1.5.1.2. ASTIGMATIC KERATOTOMY AND LIMBAL RELAXING INCISIONS
Astigmatic keratotomy, surgical procedure, was first performed in 1885 by Schiötz, a Norwegian 
ophthalmologist. 52
Several techniques of incisional surgery have been used to correct astigmatism, including 
transverse (straight) and arcuate (curved) keratotomy (AK), in which incisions are typically placed 
in the cornea at the 7 mm optical zone; and limbal relaxing incisions (LRIs), which are placed 
at the limbus.
Arcuate keratotomy is an incisional surgical procedure in which arcuate incisions of approximately 
95% depth are made in the steep meridians of the midperipheral cornea at the 7 mm optical 
zone and have greater relative depth. LRIs are incisions set approximately 50 micrones less 
than the thinnest pachymetry measurement at the limbus, and placed just anterior to the limbus. 
Due to concomitant steepening of the orthogonal meridian AK and LRI correct astigmatism 
without inducing substantial hyperopic shift of the spherical equivalent of the preoperative 
refraction. LRIs achieve increased effect primarily by increasing the length of the incision. For 
AK, cylindrical correction can be increased by increasing the length or depth of the incision, 
using multiple incisions, or reducing the optical zone. The longer and deeper the incision and 
smaller the optical zone, the greater the astigmatic correction. 53, 54
The outcome of AK and LRI surgery depends on several variables, including patient age; the 
distance separating the incision pairs; and the length, depth, and number of incisions. Few large 
prospective trials have been performed. The Astigmatism Reduction Clinical Trial (ARC-T) of 
AK, which used 7 mm optical zone and varying arc lengths, showed a reduction of astigmatism 
of 1.6 ± 1.1 D in patients with preoperative, naturally occuring astigmatism of 2.8 ± 1.2 D. Other 
AK studies have shown a final uncorrected distance visual acuity (UDVA) of 20/40 in 65-80% 
of eyes. Overcorrections have been reported in 4-20% of patients.
Studies of LRIs are limited, but these incisions are frequently used with good results in astigmatic 
patients undergoing cataract surgery. 55
With development of new surgical techniques for treatment of refractive errors, we can conclude 
that both, astigmatic keratotomy and radial keratotomy did not show effective results because 
scars on cornea never heal complitely, treated corneas are prone to infections and there is a 
tendency to hyperopic shift – they are not completely predictable.
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1.5.2. INTRACORNEAL RING SEGMENTS
Intrastromal corneal rings (ICR) are designed for modification of the corneal curvature. Intra-
stromal rings act as spacers inside the corneal stroma, leading to decreasement of central part 
of the cornea with the maintenance of physiological corneal curvature. They are usually implanted 
in the cornea at posterior 70 to 80% stromal depth through channels made mechanicaly or with 
the femtosecond (FS) laser. 56, 57 Titration of refractive correction is achieved with change in 
implantation thickness. 58 They are made of polymethilmetacrilate (PMMA), and are implanted 
deep in stroma on middle periphery of cornea leaving the pupillary area intact. Primarly were 
developed for treating nearsightness, but nowadays are used for treating keratoconus. 59, 60
Four types of intracorneal rings are available on the market, and they vary in diameter and 
geometrical profile (INTACS, Ferrara rings, Bisantis segments, Myoring). This method is 
reversible, and leads to satisfying decreasement of spherical equivalent and better remodeling 
of keratoconic corneas, but it does not stop the progression of the disease, so nowadays is used 
in combination with the crosslinking technique. 60-63
Cases of too shallow insertion of intrastromal corneal rings, endothelial perforations, postoperative 
migration of rings, stromal necrosis of cornea and infectious keratitis are reported as 
complications. 64, 65
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1.5.3. EXCIMER LASER SURGERY
1.5.3.1. SURFACE ABLATION
Photorefractive keratotomy (PRK)
Photorefractive keratotomy was developed on the idea of change in corneal curvature by means 
of ablating corneal tissue. The direct reshaping of the cornea’s central optical zone using tissue 
ablation was achieved with far ultraviolet radiation. This type of surgery was first theorized by 
New York ophthalmologist, Doctor Steven Trokel. Stephen Trokel in collaboration with Srinivasan 
Rangaswamy performed the first photorefractive keratectomy surgery in Germany. 66, 67
The first PRK procedure in a sighted eye was performed in 1987 by Theo Seiler, then at the 
Free University Medical Center in Berlin, Germany. 68
The PRK method involves mechanical removal of the epithelium (the renewable superficial layer 
of the cornea) and then remodeling of the cornea with an excimer laser. The epithelium used 
to be removed with a knife or a rotating brush. Today the epithelium is generally removed 
mechanically in cases of repeated surgery and in case of certain irregularities of the cornea, 
while in other cases it is usually removed with laser and then it is called Trans-PRK (T-PRK). 
After the treatment a “wound” is left on the eye which needs 3-5 days to heal. The surgery itself 
is not painful, but the postoperative recovery in case of this method can be uncomfortable. 
Generally, the recovery of visual acuity depends on the epithelial healing. Complete stabilization 
of vision quality often takes up to several weeks. The operation is generally suitable for patients 
with negative diopter values, up to -10.0 D with astigmatism up to -3.0 D, in mild irregularities 
of the cornea, in cases of a thin cornea and corneal scars. Hyperopic patients and patients with 
astigmatism with more than -/+ 3.0 D are not most suitable candidates for PRK method because 
of the high degree of diopter regression. 69, 70
When treating astigmatism with PRK method there is also a problem with residual astigmatism. 
It may occur based on the individual’s surface healing; some patients may end up with a small 
amount of irregular astigmatism secondary to the adjustment of epithelial cells and keratocytes. 71
The main advantage of PRK over Laser in situ keratomileusis (LASIK) is an absence of creation 
of the corneal flap and thus flap related complications. In addition, since there is no flap (which 
contains both epithelial and the deeper stromal tissues and does not contribute to corneal 
biomechanical stability) less tissue is removed with spherical or spherocylindrical correction 
leaving the cornea more biomechanically stable. It is also speculated, since there is no 
transection of deep corneal nerves, that PRK may have decreased incidence of postoperative 
dry eye. 67
In general, problems with PRK include time measured in days for epithelium to recover, followed 
by consequent pain while recovering and incidence of corneal haze. Corneal haze development 
is thought to be secondary to side effects of the cornea’s innate wound healing mechanisms. 
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Animal studies showed that, following PRK, there is an initial apoptosis of keratocytes. In 
response, some keratocytes undergo transformation to myofibroblasts. Additionally, the 
extracellular matrix produced by myofibroblasts is disorganized and denser than the usual matrix, 
and consequently scatters more light causing a haze. Incidence of haze has declined since 
refractive surgeons started using the medicine mitomycin C directly following the laser 
procedure. 72
The use of topical corticosteroids to modulate postoperative wound healing, reduce anterior 
stromal haze, and decrease regression of the refractive effect refractive effect remains 
controversial.
Regarding all the above there was obviously a need for development of some new method to 
get around the problems by keeping the epithelium and Bowman’s membrane as uninterrupted 
as possible. PRK served patients well in the past, and still does for a select few. PRK is still the 
preferred option for those with thin corneas, corneal dystrophies, corneal scars, or recurrent 
corneal erosion. 73, 74, 75
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1.5.3.2. LASER IN SITU KERATOMILEUSIS (LASIK)
In 1990, two ophthalmologists enhanced PRK method by developing what would later become 
LASIK. The term keratomileusis comes from the Greek words for “cornea” (kerato) and “to carve” 
(mileusis). Laser in situ keratomileusis, which combines keratomileusis with excimer laser stromal 
ablation, is currently the most frequently performed keratorefractive procedure because of its 
safety, efficacy, quick visual recovery and minimal patient discomfort. LASIK combines two 
refractive technologies: excimer laser stromal ablation and creation of a corneal flap.
Greek ophthalmologist Ioannis Pallikaris and Italian ophthalmologist Lucio Burrato developed 
two types of what was then known as “flap and zap”. Instead of working on top of the corneal 
surface, these doctors used a blade to cut a thin flap in the cornea, zap the tissue underneath, 
and replace the flap like a natural bandage. The flap allowed for less discomfort and a faster 
recovery. 76
In 1991 Pallikaris et al. reported usage of a modified microkeratome (an automated electric 
knife) for creation of nasally based central corneal flaps which were allowed to heal with a 
bandage soft contact lens, using neither sutures nor bioadhesives. The optical quality of the 
corneas was excellent with maintained transparency and lack of distortion of the corneal sur-
face which led to conclusion that the concept of the flap technique may be useful in laser in situ 
keratomileusis. 77
In 1993 Lucio Burrato reported one year follow up after myopic keratomileusis with the excimer 
laser and found that excimer laser myopic keratomileusis is an effective way to correct high 
myopia and may be more accurate than other methods of keratomileusis. A plano corneal disc 
was cut with a Barraquer-Krumeich-Swinger (BKS) 1000 microkeratome, followed by argon 
fluoride excimer laser ablation of the stroma. 78
Nowadays, LASIK is a lamellar laser refractive procedure which includes two steps. The first 
step is creation of the flap (partial-thickness lamellar corneal flap) usually created with the help 
of microkeratome or femtosecond laser. This method has become a popular method of refrac-
tive surgery, as it provides effective results and a short healing time. Indications for surgery are 
diopter values from -10.0 to +6.0, and up to ± 6.0 cylinders of astigmatism. 79-82
The flap, which averages in thickness from 90 to 130 micrometers (µm), is folded back to ex-
pose the underlying stroma. The excimer laser system is then focused and centered over the 
pupil and the patient is asked to look at the fixation light. After the ablation is complete, the flap 
is replaced onto the stromal bed. The physiological dehydration of the stroma by the endothelial 
pump will begin to secure the flap in position in several minutes. Patients are instructed not to 
rub or squeeze their eyes. 83-88
The main advantage of LASIK over PRK is related to maintaining the central corneal epithelium. 
This increases comfort during the early post-operative period, allows for rapid visual recovery, 
less discomfort after surgery and reduces the wound healing response. Reduced wound healing 
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correlates with less regression for high corrections and a lower rate of complications such as 
significant stromal opacity (haze). Many advantages are related to preservation of the central 
corneal epithelium and epithelial basement membrane during LASIK. 87
However, LASIK is not without complications. The creation of the lamellar flap during the LASIK 
procedure increases the risk of intraoperative and postoperative complications. Flap related 
complications such as incomplete or perforated flaps, intraoperative or postoperative flap 
distortions account for up to 15% of complications. Those complications are much higher with 
mechanical microkeratomes than femtosecond laser. From postoperative complication there 
are deep lamellar keratitis as non-infectious complications, and extremely rare microbial 
inflammations. The potentially most devastating late postoperative complication is corneal ectasia 
which is directly linked to severed corneal biomechanics caused by abundant thinning of the 
cornea. Other complications are prolonged dry eye, reduced vision in low lighting conditions, 
and visual distortions such as glare and haloes can still occur in up to 1-2% of cases. 86, 89
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1.5.4. LENS SURGERY
1.5.4.1. PHAKIC LENSES
For patients not suitable for corneal surgery, implantation of phakic intraocular lens (pIOL) can 
be a good alternative. 90
Phakic lenses PIOLs have the advantage of treating a much larger range of refractive errors 
than can be treated safely and effectively with corneal refractive surgery. Phakic IOLs have a 
number of advantages such as preserving corneal tissue and decreasing the risk of ectasia, 
maintaining the corneal shape without inducing high order aberrations and the possibility of 
pIOL removal. 91
PIOLs are removable, therefore, the refractive effect should theoretically be reversible. Im-
plantation of these lenses has the advantage of preserving natural accommodation and com-
pared with refractive lens exchange has lower risk of endophthalmitis and postoperative retinal 
detachment because of the crystalline lens barrier which is preserved and there is a minimal 
vitreous destabilization.
Currently, there are two types of pIOL: anterior chamber pIOL and posterior chamber pIOL.
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1.5.4.1.1. Anterior chamber phakic IOLs
Anterior chamber pIOLs can be divided as (1) iris-fixated IOLs and (2) angle-supported IOLs.
Angle supported lenses are not in use any more, while iris fixated lenses come in rigid and 
foldable version. The diopter range of those lenses is from -3.00 D to -23.50 D, and from +1.00 D 
to +12.00 D in 0.50 D steps. Toric version is also available in minus cylinder notation to up to 
7.50 D. 92-97
Iris-fixated toric phakic IOLs are available in both rigid PMMA (Verysise toric, Artisan toric) and 
foldable silicone (Artiflex toric) versions. The rigid lens has 5.0 mm optic, while the foldable 
version has 6.0 mm optic. Both lenses have a total diameter of 8.5 mm and are available in 
spherical ranging from -3.00 D to -23.50 D and +2.00 D to +12.00 D, with cylinder powers ranging 
from 1.00 D to 7.00 D in 0.50 D steps. 98, 99
1.5.4.1.2. Posterior chamber phakic IOLs
Posterior chamber pIOLs are placed behind the pupil and in front of the lens with haptics placed 
in sulcus. At this moment posterior chamber pIOLs are the prefered (most commonly implanted). 
The diopter range of those lenses is from -1.00 D to -18.00 D, and from +1.00 D to +8.00 D in 
0.50 D steps. Toric version is also available in minus cylinder notation to up to 6.00 D. 100
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1.5.4.2. REFRACTIVE LENS EXCHANGE-CLEAR LENS EXTRACTION
Refractive errors can also be resolved surgically by IOL implantation procedure, called refractive 
lens exchange. For astigmatism correction toric IOLs are used. Those lenses have different 
powers in different meridians of the lens. They also have alignment markings on the peripheral 
part of the lens that enable the surgeon to adjust the orientation of the IOL inside the eye for 
optimal astigmatism correction. Achieving success with toric IOLs depends on the selection of 
suitable patients. Depending on the toric IOL model, the minimal available toric IOL power at 
the IOL plane is 1.00 D or the 1.50 D. At the corneal plane, this corresponds to a minimal corneal 
power of approximately 0.75 to 1.00 D, respectively. Taking into consideration the amount of 
astigmatism induced by the surgery, patients must have a corneal astigmatism of at least 1.00 
to 1.25 D in order to be candidates for a toric IOL. Regarding corneal astigmatism patients with 
regular bow-tie astigmatism are most suitable for toric IOL implantation. Corneal topography is 
therefore important for detecting irregular astigmatism and keratoconus. 101, 102 
Astigmatism correction with Toric IOL does not affect the cornea. 103
There are two types of toric version of IOLs – toric monofocal lenses and toric multifocal lenses.
Toric monofocal lenses have one spherical component combined with astigmatism component. 
They are designed to correct for distance vision, while near vision is corrected with spectacles.
Toric multifocal lenses can have bifocal, trifocal or extended depth of focus optics designed to 
correct vision at all distances. 103
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1.6. ASTIGMATIC LASER IN SITU KERATOMILEUSIS
When treating astigmatism several factors must be carefully considered:
•	 Residual	error	can	be	present	despite	all	efforts
•	 The	residual	axis	may	be	disturbingly	different	from	the	preoperative	axis
Regular astigmatism is mainly generated by excessive corneal toricity. Corneal toricity can be 
suppressed either by flattening the steepest meridian to match the curvature of the initially flatter 
meridian or by steepening the flattest meridian to match the curvature of the initially steeper 
meridian. Simple myopic and hyperopic astigmatic treatments rely on the use of negative and 
positive cylinder modes, respectively. Compound and mixed astigmatism are treated by the 
combination of negative and/or positive cylindrical and spherical modes. When dealing with 
high compound astigmatism deeper ablation is required and thus, a greater curvature gradient 
between the center and periphery is created. 104
Standard ablation patterns for astigmatic correction treat only the steeper meridian, leaving the 
flatter meridian unchanged. This, in turn, creates poor transition zones along the steeper meridian 
and unphysiologically abrupt dioptric curvature gradients, resulting in a midperipheral multifocality 
of the cornea. The poor transition zones achieved by treating only one meridian lead to an 
abnormal healing response, and cause an overcorrection of the sphere and under-correction 
as well as regression of the cylinder. 105
Mixed astigmatism remains one of the most challenging defects for refractive surgery. 
Advancements in the correction of mixed astigmatism include pursuit of a postoperative corneal 
surface that is as symmetrical as possible, centrally as well as in the periphery. 106
In the past several ablation patterns have been proposed for the treatment of mixed astig-matism: 
correction on the steep meridian (myopic cylinder ablation + hyperopic sphere ablation), 
correction on the flat meridian (hyperopic cylinder ablation + myopic sphere ablation), cross-
cylinder ablation, and bitoric ablation (asymmetrically split on two meridians). 107-109
Azar, in a thorough analysis of various available methods, recommended correction on the 
hyperopic meridian only with the advantage of removing less cornea than with any other 
technique. 110
1.6.1. CORNEAL BIOMECHANICAL RESPONSE
A revolutionary approach to the problem of unpredictability has been introduced by Cynthia 
Roberts with the concept of corneal biomechanical response to laser ablation.111
The concept is based on the anatomical lamellar structure of the corneal stroma and on its 
tensile strength: central severing of lamellae due to creation of new refractive surface by excimer 
laser tissue removal causes elastic contraction of the remaining peripheral lamellae with 
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consequent corneal curvature variation. This results in peripheral corneal increase in curvature, 
thickness and central flattening, leading to refractive change just where the curvature was 
carefully modified to achieve a planned power.
A delicate point in the creation of a new surface with excimer laser ablation is transition zone. 
In both stromal and surface ablation, marked variation of curvature in this peripheral portion 
leads to a response aimed to reduce curvature variation, but may induce regression and 
restriction of the effective optical zone. 111
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1.6.2. CYCLOTORSION
Cyclotorsion is the rotation of an eye around its visual axis. Throughout the LASIK procedure, 
cyclotorsion of the globe occurs continually, leading to misalignment of the axis if this effect is 
not taken into consideration. Cyclotorsion can lead to a decrease in the amount of astigmatism 
reduction. Mean cyclotorsion of the human eye during laser application in the supine position 112, 113 
has been calculated to be 2.670 ±1.588°. With 10° deviation of an astigmatic ablation from the 
intended axis, approximately one-third of the astigmatism-correcting effect is lost, and with 20° 
of axis deviation, approximately two-thirds of the effect is lost. Misalignment greater than 30° 
produces a net worsening of astigmatism. 112, 113
Bharti et al. 114 found that active cyclotorsion compensation during LASIK for myopic astigmatism 
increases the accuracy of cylinder correction.
Extensive cyclotorsional movement is a clinical reality, and it can result in significant optical 
errors. Since laser ablation applies unaccounted eccentric focal ablations, cyclotorsion during 
ablation may cause inaccurate positioning of spots, hypocorrection, cylinder axis deviation, and 
induction of aberrations. Postoperative high order aberrations may be less tolerated than residual 
refractive error, and cannot be corrected with spectacles. Compensation with automated 
cyclotorsional tracking is necessary to optimize the benefits of ablations. 115
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1.7. MICROKERATOME
First manual mechanical microkeratome was designed by José Ignacio Barraquer in 1958, and 
was intended for keratophakia and frozen keratomileusis. 116
First mechanical (automated) microkeratome with nasal hinge – Castrovievo microkeratome was 
built in 1963. Automated microkeratomes came into clinical use in 1991 for automated lamellar 
keratoplasty with Ruiz and Lenchig’s Chiron and were called “automated corneal shaper”. 117
Modern microkeratomes available on today’s market can create all sorts of adjusted flaps. Every 
microkeratome has its specific characteristics that determine size, shape and thickness of the 
flap together with size, shape and position of the hinge. Today’s microkeratomes offer high level 
of security, but the risk of complications is still not completely eliminated. 83
Microkeratome is an automated electric knife, which works like a carpenter’s plane and is used 
for the creation of the corneal flap. Before the surgery, the microkeratome and vacuum unit are 
assembled, inspected and tested to ensure proper functioning. After a suction ring has been 
properly positioned, suction is activated. The suction ring has 2 functions: to adhere to the globe, 
providing a stable platform for the microkeratome cutting head; and to raise the IOP to a high 
level, which stabilizes the cornea. Intraocular pressure should be raised to over 65 mmHg. The 
dimensions of the suction ring determine the diameter of the flap and the size of the stabilizing 
hinge. The thicker the vertical dimension of the suction ring and the smaller the diameter of the 
ring opening, the less the cornea will protrude, and hence a smaller-diameter flap will be 
produced. The suction ring is connected to a vacuum pump, which is typically controlled by an 
on–off foot pedal. Hinge positions, nasal or superior, depend on the design of the microkeratome, 
and are at the surgeon’s discretion. 83, 117
First generations of microkeratomes had problems during LASIK surgery, such as loss of suction, 
creation of flaps with irregular edges and wide variations of thickness and shape of the flaps. 
In the last three decades the quality, speed, precision and efficacy of mechanical microkeratomes 
have been constantly improving, which led to a significant increase in safety and precision of 
the surgery. 
Last generations of microkeratomes allow very precise flap creation with regular edges and 
predetermined thickness and shape. The procedure lasts only few seconds and does not create 
any discomfort to the patient. Flaps are usually 90-100 µm thick which makes a huge improvement 
compared to flaps created with older types of microkeratomes.
Microkeratomes are devided according to the movement of dissection head. Nowadays mostly 
used microkeratomes use linear, arcuate or pendular movement.
Linear movement (translation) – dissecting head is lead over two parallel tracks in horizontal 
plane. Linear microkeratomes have an option to create only nazal hinge. (Table 1)
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Arcuate movement (translation) – dissecting head is lead over horizontal plane over eccentric 
axis circular track. Arcuate microkeratome has multiple options for hinge position. (Table 1)
Pendular movement (translation) – dissecting head is lead like a swing over a horizontal plane 
above corneal apex. Part of a vacuum ring, in touch with cornea, has a convex shape, and 
dissecting head is in a shape of hemisphere which ensures constant thickness of the flap. (Table 1)
Microkeratomes for single and multiusable purposes
Majority of microkeratomes are reusable after disassembling, cleaning and sterilization. Only 
exception is the blade which is always exclusively made for single use. All peripheral components 
– silicone tubes, dissecting head with previously inserted blade, and vacuum rings can be 
created only for single use.
31
Prospective comparison of two excimer laser platforms in treatment of high astigmatism with laser in situ keratomileusis
TABLE 1. Display of basic characteristics of comercially available microkeratomes
MANUFACTURER
MODEL OF 
MICROKERATOME
TYPE OF
MOVEMENT
FLAP
THICKNESS
STANDARD
DEVIATION
(µm)
FLAP
SIZE
(mm)
HINGE
POSITION
ZIEMER Amadeus II168,169 Linear
140-160-
200-250-
300-350-
400-450
Not available 8,5-10 Superior/nasal
MORIA
M2 single use 90168, 170
SBK One Use + 90168, 171
Arcuate 
Linear
110-130
100
±15
±8
8-11
8,8-
10,5
Superior
Nasal
MED Logics ML 7168, 172 Linear 100-130 ±9 7,5-10
360° –
possibility of
choosing the
Position
SCHWIND Carriazo-Pendular168, 173 Pendular
90-110-130-
150-170
±10-12 9-10
360° –
possibility of
choosing the
Position
Data about characteristics and performance of microkeratomes available at manufacturers links 83, 180-184
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1.8. FEMTOSECOND LASERS
Femtosecond laser technology was first developed by Dr. Kurtz at the University of Michigan 
in the early 1990s118 and was rapidly adopted in the surgical field of ophthalmology.
1.8.1. PHYSICAL PRINCIPLES OF FEMTOSECOND LASERS
Femtosecond lasers emit light pulses of short duration (10−15 s) at 1053 nanometers (nm) 
wavelength that cause photodisruption of the tissue with minimum collateral damage. 119-122 
This enables bladeless incisions to be performed within the tissue at various patterns and depth 
with high precision.
Femtosecond lasers are solid state lasers and can be focused anywhere within the cornea 
where the energy can be raised to a threshold such that a plasma is generated. 123
Laser is based on the principle of nonlinear apsoption (which means that corneal tissue is 
transparent for infrared laser radiation of moderate intensity and it doesn’t lead to apsorption) 
and on the principle of photoionisation (laser induces optical break down), which leads to 
photodisruption in a focal point. The final result is creation of fast spreading cloud of free ions 
and ionisating molecules (plasma). Small volumes of tissue are vaporised with formation of 
cavitation bubbles of gas that gradually spread in nearby tissue, and they consist of carbon 
dioxide and water. Main characteristics of femtosecond laser is that it is possible that low energy 
of pulse can achieve high power. 124-131
The femtosecond laser is used primarily to create a LASIK flap within the corneal stroma. The 
laser allows precise control of flap architecture not obtainable with a traditional mechanical 
microkeratome. 132-134 Once the LASIK flap is created, an excimer laser is used to reshape the 
cornea.
Nowadays creation of the flaps in LASIK procedure with the use of femtosecond lasers is 
becoming more and more popular, because of its advanced precision of creation controlled by 
laser beams and higher intraoperative safety (lower risk of intraoperative complications), and 
the future of refractive surgery is heading to that direction. 135, 136 Femtosecond lasers have 
growing popularity in ophthalmic surgery and besides flap creation, which is their most common 
use, they are also used for relaxing limbal incisions, astigmatic keratotomies, creation of 
intrastromal tunnels for intracorneal ring segments and intrastromal pockets for inlay insertion 
and also drug delivery. Nowadays, they are also used as a single refractive devices in refractive 
surgery with a novel refractive surgery procedures such as Refractive Lenticule Extraction 
(ReLex Flex), Small incision lenticule extraction (ReLex Smile) and presbyopia correction in 
terms of Intrastromal presbyopia correction (Intracor) procedure. Different types of femtosecond 
lasers are also introduced in cataract surgery and are able to perform incisions, capsulorhexis 
and lens fragmentation.
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1.9. EXCIMER LASERS
1.9.1. EXCIMER LASER PRINCIPLE OF WORK
The excimer laser is based on the combination of two gases: a noble gas and halogen. Both of 
these are generally stable in their normal low-energy state. When a high-voltage electrical 
discharge is delivered into the laser cavity containing these gases, the gases combine to form 
a higher energy excited-gas state compound. The term “excimer” is derived from a contraction 
of “excited dimer”. On the dissociation of this high-energy compound, a photon of energy is 
released that corresponds to the bond energy of the noble gas-halogen molecule. 137, 138
This wavelength of light energy is amplified in the laser system, resulting in the production of a 
discrete high energy pulse of laser energy. The specific wavelength of an excimer laser depends 
on the composition of the gases used in the laser system. Excimer laser systems in current 
clinical use rely on argon and fluorine gases. The argon-fluorine excimer lasers emit energy at 
a wavelength of 193 nm. This wavelength falls in the UV-C range of the light spectrum. In 
contrast, the krypton-fluoride excimer laser used in early laboratory studies emits a wavelength 
of 248 nm. 139, 140
Laser energy at 193 nm is very well absorbed by the proteins, glycosaminoglycans and nucleic 
acids comprising the cornea. Since 193 nm photon is of higher energy than the molecular bond 
strength of these compounds, absorption of the laser energy results in breaking of the bounds. 
The resulting molecular fragments are ejected from the surface of the cornea at supersonic 
speeds. 140-142
It is important to understand that the excimer laser does not cut tissue like a scalpel; rather it 
ablates or removes tissue from the corneal surface. The ablated material appears as an effluent 
plume that upon analysis has been shown to consist of a variety of high-molecular-weight 
hydrocarbons. 143
There is a concern about the potential for mutagenesis or carcinogenesis with any laser radiation, 
especially in the ultraviolet light spectrum. Studies have been done showing that the 193 nm 
excimer laser is neither mutagenic nor carcinogenic. 144, 145
This may be in part a result of shielding of the nucleus by the cell’s cytoplasm.
Several attributes of the argon-fluoride excimer laser ablation make it particularly appropriate 
for corneal sculpting. The laser energy is well absorbed near the corneal surface and, thus, 
should have few deep direct or secondary mechanical (shock-wave) effects on the corneal 
tissue. The ablation process is rapid, and excess energy is ejected with the effluent plume. 145
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There is minimal thermal damage to the surrounding tissue. Because of these qualities, the 193 
nm excimer laser can be used to meticulously reshape large areas of the corneal surface while 
minimizing damage to remaining tissue. 146
The excimer laser technique is qualitatively different from refractive surgical techniques such 
as radial or astigmatic keratotomy, which achieves corneal reshaping through biomechanical 
changes mediated through thin knife incisions.
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1.9.2. TYPES OF EXCIMER LASERS
The first-generation excimer lasers were “broad beam lasers” or “full beam lasers“ that created 
less uniform surface profiles than the newer generations. Full beam enables faster treatment 
(for given frequency) and is less sensitive for decentration, but homogenizes slower, gives 
irregular treatment of the surface and has more expressed thermal effect. It is needed to use 
masks for achievement of desired treatment form, and it is not possible to perform custom 
treatments. 146
Newer-generation of excimer lasers use scanning beams or flying spots, with smaller spot sizes 
and more efficient eye trackers. Systems for scanning slit delivery act like flying spot systems 
and it exceled some limitations of full beam systems, but maintained the speed of the treatment 
and low decentration sensitivity. System uses additional diaphragm between full beam and the 
eye, which flows through hexagonal beam of a smaller diameter (10 mm x 1 mm) to the eye, 
and improves homogeneity of the beam. Ablation masks rotate, enabling performance in different 
directions. 146
Flying spot systems convert laser beam in small round spot (between 0.6 and 2.0 mm). System 
uses only central most homogenic part of the beam, and beam direction is controlled by a mirror 
with rotation function. Ablation of targeted tissue is performed by repeated delivery of high 
number of pulses, in which every pulse removes only small area of tissue. Very high frequency 
is needed to shorten the treatment period, especially if the spots are very small. Also, spots 
need to be distributed precisely to avoid thermal effect. During that time eye tracking system is 
obligatory, because it is very sensitive to decentration. Energy profile of every spot is Gaussian 
and enables smooth areas of ablation, and the distance between two aiming spots is half of a 
beam size so the regular ablation can be provided. Main advantage of these systems is possibility 
of treatments high levels of irregularities. The smaller the spot, the treatment option of 
irregularities is higher. 146
Although excimer machines from different manufacturers converge in technology, individual 
lasers differ in laser ablation algorithm, eye-tracking technology, frequency of laser ablation, 
corneal thickness ablated, duration of treatment, and physical design.
36
Prospective comparison of two excimer laser platforms in treatment of high astigmatism with laser in situ keratomileusis
1.9.2.1. Pulse duration
Pulse arises during highest instability of excited dimer (half-time break up from 9 to 23 ns) and lasts 
10 to 20 ns. The shorter the pulses, the less influence of thermal effect is on the nearby tissues. 146
1.9.2.2. Pulse frequency
Frequency of pulses (number of pulses emitted in a second) varies from 10 to 1050 Hz depending 
on laser model. The higher the frequency – treatment is faster, but the thermal effect is higher, 
so the cooling of the treated tissue is ensured by using different algorithms. Optimal laser frequency 
with full beam is from 10 to 50 Hz, while with flying beam lasers it goes up to 1050 Hz, and the 
speed depends on success of algorithm for positioning sequent pulse strikes. 146
1.9.2.3. Pulse energy
Energy that the pulse is delivering varies from 10 to 250 mJ depending on the laser. Difference 
in pulse energy can be up to 10%. During typical refractive procedure variation on the depth of 
tissue penetration is ±0,1% (which corresponds to 0,1 D) so it is negligible in clinical practice. 146
1.9.2.4. Constant energy of radiation on measured area
Step of photoablation on the corneal surface of 193 nm wavelenght is 50 mJ/cm2. Below this 
step photoablation is irregular and incomplete. Every pulse with constant energy of radiation 
above minimal step precisely removes certain amount of corneal tissue. Amount of tissue that 
pulse removes is increasing linearly with energy increase up to the values of 600 mJ/cm2. After 
that value, increase of radiation energy is not increasing the amount of tissue removed by pulse. 
Constant radiation energy depends on the type of laser, and goes from 160 i 250 mJ/cm2. 146
1.9.2.5. Degree of ablation
Degree of ablation goes from 0,25 to 0,6 µm by pulse hit, and is typical for every laser. Many 
factors have influence on ablation degree. Every histological layer of the cornea has different 
ablation degree (ablation of epithelium is faster than stromal ablation, while stromal ablation is 
30% faster of Bowman’s membrane ablation). Scaring slows down the ablation, while dehydration 
of the tissue accelerates it. 146
Conventional laser refractive surgery platforms are capable of correcting lower-order aberrations, 
such as hyperopia, myopia, and astigmatism. Higher-order aberrations (HOAs) such as coma, 
spherical aberration and trefoil are induced by, and remain uncorrected in traditional laser in 
situ keratomileusis (LASIK) surgery. 147, 148
The HOAs call for more advanced optical measurements and more sophisticated laser 
algorithms. These laser algorithms are found in wavefront (WF) based treatments, which have 
been shown to diminish induced HOAs compared to traditional LASIK, and increase predictability 
of visual outcomes. 147-157
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1.9.3. COMMERCIALY AVAILABLE EXCIMER LASERS
Wavelight Allegretto – is a flying-spot excimer laser, with a pulse repetition rate from 200 to 500 
Hz depending on the laser model, with two galvanometric scanners for positioning laser pulses. 
The beam is a small-spot, <0.95 mm in diameter, with a Gaussian energy distribution. It has a 
short treatment time of 2 seconds per diopter. The system has an infrared high-speed camera 
operating at 400 Hz to track the patient’s eye movements that either compensates for changes 
in eye position or interrupts the treatment if the eye moves outside a present predetermined 
range. The tracker has automatic pupil cantering and an integrated cross-line projector for 
alignment of the head and eye position, with a “NeuroTracker” for cyclotorsion control for the 
wavefront-optimized algorithm. Its eye-tracker system and laser trigger are synchronized. Its 
optimized ablation profile is designed to maintain a more natural corneal shape by adjusting for 
the asphericity of the cornea based on the anterior curvature readings (providing more treatment 
to the periphery than centrally), and minimizing the amount of spherical aberration induced 
during surgery. 158, 159 The laser also features the ability to perform custom treatments (topography 
guided). The company supplies a nomogram chart, which recommends a standardized reduction 
in treatment for high degrees of myopia and cylinder. For low myopia, an increase in treatment 
is recommended instead. (Table 2)
FIGURE 10. Wavelight Allegretto Eye-Q 400 Hz laser platform
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Schwind Amaris - is a flying-spot excimer laser with a pulse repetition rate of 500 to 1050 Hz 
depending on the laser model and produces a beam size of 0.54 mm Full-Widthat-Half-Maximum 
(FWHM) with a super Gaussian ablative spot profile. It has a short treatment time of less than 
2 seconds per diopter. Inside the software package the laser is able to perform aspheric 
and custom (topography and ocular guided) treatments. Its aspheric (“Aberration-FreeTM”) 
ablation algorithm is designed to maintain the preoperative levels of ocular higher-order 
aberrations. 160-163 
Aspheric aberration neutral 164 (Aberration-FreeTM 165 profiles are not based on the Munnerlyn 
proposed profiles,166 and go beyond that by adding some aspheric characteristics to balance 
the induction of spherical aberration (prolateness optimization). The profile is aspherical-
based, including a multidynamic aspherical transition zone, aberration and focus shift 
compensation due to tissue removal, pseudo-matrix based spot positioning, enhanced 
compensation for the loss of efficiency, and intelligent thermal effect control; all based on 
theoretical equations vali-dated with ablation models and clinical evaluations.
Depending on the planned refractive correction, approximately 80% of the corneal ablation is 
performed with a high fluence level (>400 mJ/cm²) and this leads to a considerable reduction 
in time spent treating the cornea. Fine correction is performed for the remaining 20% of the 
treatment using a low fluence level (<200 mJ/cm²), aimed to reduce the amount ablated per 
pulse and smooth out the ablated stromal bed. The laser features a six-dimensional 1050 Hz 
infrared eye tracker with simultaneous limbus, pupil, iris recognition, and cyclotorsion 
tracking integrated in the laser delivery process. (Table 2)
FIGURE 11 . Schwind Amaris 750S laser platform
Schwind Amaris – is a flying-spot excimer laser with a pulse repetition rate of 500 to 1050 Hz 
depending on the laser model and produces a beam size of 0.54 mm Full-Widthat-Half-Maximum 
(FWHM) with a super Gaussian ablative spot profile. It has a short treatment time of less than 
2 seconds per diopter. Inside the software package the laser is able to perform aspheric and 
custom (topography and ocular guided) treatments. Its aspheric (“Aberration-FreeTM”) ablation 
algorithm is designed to maintain the preoperative levels of ocular higher-order aberrations. 160-163
Aspheric aberration neutral 164 (Aberration-FreeTM 165 profiles are not based on the Munnerlyn 
proposed profiles, 166 and go beyond that by adding some aspheric characteristics to balance 
the induction of spherical aberration (prolateness optimization). The profile is aspherical-based, 
including a multidynamic aspherical transition zone, aberration and focus shift compensation 
due to tissue removal, pseudo-matrix based spot positioning, enhanced compensation for the 
loss of efficiency, and intelligent thermal effect control; all based on theoretical equations 
validated with ablation models and clinical evaluations.
Depending on the planned refractive correction, approximately 80% of the corneal ablation is 
performed with a high fluence level (>400 mJ/cm²) and this leads to a considerable reduction 
in time spent treating the cornea. Fine correction is performed for the remaining 20% of the 
treatment using a low fluence level (<200 mJ/cm²), aimed to reduce the amount ablated per 
pulse and smooth out the ablated stromal bed. The laser features a six-dimensional 1050 Hz 
infrared eye tracker with simultaneous limbus, pupil, iris recognition, and cyclotorsion tracking 
integrated in the laser delivery process. (Table 2)
FIGURE 11. Schwind Amaris 750S laser platform
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Mel (Carl Zeiss Meditec AG, Jena, Germany) – available in two laser models (Mel 80 and Mel 
90–250 Hz, 500 Hz). Laser has Gaussian profile of laser beam with aiming spot of 0,7 mm. 
Overheating of corneal surface is controlled with nonrandomised arrangement of aiming spots, 
and atmosphere and homogenisation of ejected gasses over cornea is controlled with specially 
designed extension. On 500 Hz model eye tracker system works in infrared spectrum on a 
frequency of 1050 Hz, and registers limbus of cornea and edge of a pupil. Both models are 
equipped with software for custom treatments. 167 (Table 2)
Star S4 IR (Abbot Medical Optics, Santa Ana, California, USA) – is a laser which beam has 
adjustable size of aiming spot that variates from 0,65 to 6,5 mm. Laser works on a frequency 
of 10/20 Hz, and has incorporated 3D iris recognition eye tracking system with speed of 60 Hz. 
Software program of the laser enables custom treatments also. 168, 169 (Table 2)
Technolas 217z (Bausch & Lomb, Rochester, New York, USA) – laser that works with speed of 
100 Hz with laser beam of truncated Gaussian profile and size of aiming spot of 2 mm. Thermal 
damage of corneal surface is controlled with overlapping form of aiming spots. It has 6D eye 
tracking system incorporated founded on iris recognition, and compensates movements on x/y/z 
axis, static and dynamic cyclotorsion, and iris movements. Software program besides custom 
treatments enables treatment of presbyopia with “Supracor” method. 170-172 (Table 2)
Nidex Quest/EC-5000 CX III (Nidek CO Ltd, Gamagori, Japan) – is “scanning slit laser” which 
cuboid beam is divided into six equal aiming spots with 1 mm size Gaussian profile. Laser works 
on 100 Hz frequency and has incorporated 6D eye tracking system, speed of 1 kHz. Software 
program enables custom ablations. 173 (Table 2)
TABLE 2. Display of basic characteristics of excimer lasers available on the market
CHARACTERISTICS WAVELIGHTEX500
SCHWIND
AMARIS
1050
MEL 90 STAR S4IR (VISX)
TECHNOLAS
217P
NIDEK
Quest/EC-
5000 CX III
Type of ablation “Flying spot“ “Flying spot“ “Flying spot“ Adjustablespot size “Flying spot“
“Scanning
slit“
Beam profile Ultra-thinGaussian profile
Super
Gaussian
Profile
Gaussian
Profile
Gaussian
Profile
Truncated
Gaussian
profile
Gaussian
Profile
Spot size (mm) 0,68 0,54 0,7 0,65-6,5 1-2 1
Pulse frequency (Hz) 500 1050 250/500 10-20 100 100
Speed of eye
tracking system (Hz) 1050 1050 1050 60 240 200/1000
Characteristics of
eye tracking system 6D tracking system
7D tracking
system
Registration
of pupil edge
and limbus
3D tracking
system
6D tracking
system
6D tracking
system
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2. HYPOTHESIS
Schwind Amaris 750S provides superior refractive results when treating high astigmatism 
compared to Wavelight Allegretto Eye-Q. Aberration free program of Schwind induces less high 
order aberrations (HOAs) than Wavelight optimized treatment.
41
Prospective comparison of two excimer laser platforms in treatment of high astigmatism with laser in situ keratomileusis
3. AIMS OF THE RESEARCH
1. To analyse functional parameteres after performed LASIK- uncorrected (UDVA) and corrected 
distant visual acuity (CDVA), residual refractive error, astigmatism outcomes by means of vector 
analysis and high order aberrations in patients with high astigmatism (more than 2 diopters (D)) 
treated with Wavelight Allegretto Eye-Q laser platform.
2. To analyse functional parameters after performed LASIK- uncorrected (UDVA) and corrected 
distant visual acuity (CDVA), residual refractive error, astigmatism outcomes by means of vector 
analysis and high order aberrations in patients with high astigmatism (more than 2 diopters (D)) 
treated with Schwind Amaris 750S laser platform.
3. To investigate the differences in uncorrected distant visual acuity (UDVA) in patients treated 
with two different excimer laser platforms.
4. To investigate the differences in corrected distant visual acuity (CDVA) in patients treated with 
two different excimer laser platforms.
5. To investigate the differences in residual refractive error in patients treated with two different 
excimer laser platforms.
6. To determine the significance in the astigmatism outcomes by means of vector analysis in 
patients treated with two different excimer laser platforms.
7. To investigate the differences in high order aberrations in patients treated with two different 
excimer laser platforms.
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4. PATIENTS AND METHODS
4.1. PATIENTS
Research was performed at University Eye Hospital Svjetlost in Zagreb, Croatia. Patients were 
included between January 2010 and December 2011, and had a follow up of one year. During 
the inclusion period 3503 patients were examined for laser eye surgery at the Cornea and 
Refractive Surgery Department. Out of 3503 patients, 1020 patients were not suitable for excimer 
laser surgery because of their high refractive error and/or inadequate ratio of refractive error 
and corneal thickness, which was out of the safety limit for the laser eye surgery (163 patients), 
plano presbyopic patients or combination of refractive errors – myopia/ hypermetropia with 
presbyopia (572 patients), lens opacities (118 patients), irregularities of the cornea and/or ectatic 
corneal diseases (60 patients), retinal problems (45 patients), injuries of the eye (34 patients) 
and newly discovered glaucoma patients (28 patients).
Out of 2483 patients, PRK method was recommended for 350 of them. Out of 2183 patients 
who were suitable for LASIK 274 patients who met the criteria were included in the study.
Two hundred and seventy-four patients (470 eyes) with astigmatism more than 2 diopters (D) 
were operated and two hundred and thirty seven patients (418 eyes) completed one year of 
follow-up. Operation was performed on two hundred and seventy four patients (274) instead of 
planned two hundred sixty (260) patients needed for the study, taking into account that some 
patients can be lost in the follow up period. Exactly that situation occurred. Two hundred and 
thirty-seven (237) patients actually made visits for control examinations, but that number is less 
than percentage allowed in the proposal, so data of the research is valid (up to 15% loss of 
patients is considered allowed for needed data of this research).
The inclusion criteria were: patients over 18 years of age with a refractive error stable for at 
least	one	year,	astigmatism	≥2.0	D,	corneal	thickness	≥500	micrometers	(μm),	mesopic	pupil	
≤7.5	millimeters	(mm),	and	unremarkable	corneal	topography.	Patients	with	peripheral	retinal	
degeneration were evaluated by specialists and subjected to argon photocoagulation before 
the refractive procedure when indicated.
Exclusion criteria were topographic patterns that were suggesting any form of ectatic corneal 
disease, and systemic or ocular diseases that could interfere with the healing process of the 
cornea. Patients with previous ocular surgery were also excluded.
Patients were separated into two groups according to the laser platform on which they were 
treated – Wavelight Allegretto Eye-Q 400 Hz and Schwind Amaris 750S. Within each group, 
the treated eyes were further subdivided according to the type of astigmatism, myopic astigmatism 
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or mixed astigmatism. A total of 188 eyes (110 patients) were included in the Allegretto group. 
There were 127 eyes (71 patients) with myopic astigmatism and 61 eyes (39 patients) with mixed 
astigmatism. A total of 230 eyes (127 patients) were included in the Amaris group. There were 
119 eyes (64 patients) with myopic astigmatism and 111 eyes (63 patients) with mixed astigmatism.
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4.2. METHODS
4.2.1. PREOPERATIVE EXAMINATION
Every patient had complete preoperative ophthalmologic examination prior to deciding if the 
patient met the criteria for corneal refractive surgery. Examination included uncorrected and 
corrected distant visual acuity (UDVA, CDVA), manifest and cycloplegic refraction, corneal 
topography measured on pentacam (Pentacam HR, Oculus Optikgeräte GmbH, Wetzlar, 
Germany), aberrometry (L 80 wave+, Luneau SAS, Prunay-le Gillon, France), tonometry (Auto 
Non-Contact Tonometer, Reichert Inc., Buffalo, NY, USA), slit-lamp and dilated funduscopic 
examination. Visual acuity was measured using a standard Snellen acuity chart at 6 m and 
presented in decimal format. The patients were asked to discontinue use of contact lenses for 
up to 4 weeks prior to this examination, depending on the type of lenses they were using.
Patients	with	stable	refraction,	astigmatism	≥2.0	D,	regardless	of	the	amount	of	myopic	or	
hyperopic spherical correction, were included. Ocular criteria were those normally adopted in 
refractive surgery. Patients with history of ocular surgery, abnormal corneal topography, 
preoperative	corneal	thickness	<490	μm	or	calculated	residual	stromal	bed	thickness	<280	μm	
were excluded from the study.
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4.2.2. VISUAL ACUITY MEASUREMENT
Uncorrected and corrected distant visual acuity were measured on a digital screen (Clear Chart 
4 Digital Acuity, Reichert Technologies, Buffalo, New York, USA). For testing Snellen chart with 
Sloans letters was used. The chart has letters of different sizes arranged from largest at the top 
to smallest at the bottom, which are read, one eye at a time, at a distance of 6 meters (20 feet). 
Each letter on the chart subtends an angle of 5 minutes (min) of arc at the appropriate testing 
distance, and each letter part subtends an angle of 1 min of arc. Thus, it is designed to measure 
acuity in angular terms. Snellen acuities are usually expressed as a fraction with the numerator 
equal to the distance from the chart and the denominator being the size of the smallest line that 
can be read. The reciprocal of the fraction equals the angle, in min of arc, that the stroke of the 
letter subtends on the patient’s eye and is called the minimum angle of resolution (MAR).
For maximal visual acuity the row in which patients did not see and/or misread maximum two 
letters – was recorded (entered); in the case where there was larger number of misread letters 
visual acuity of previous row was taken into account. Visual acuity was expressed as a decimal 
that is equal to the numeric value of the Snellen fraction or the reciprocal of the visual angle in 
minutes, so 20/20 would become 1.0. 174
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4.2.3. HIGH ORDER ABERRATIONS MEASUREMENT
Total ocular high order aberrations were evaluated – coma, trefoil and spherical aberrations. 
Measurements were performed by Luneau Visionix L 80 Wave+ aberrometer, based on Hartman 
Shack sensor (Visionix, Prunay-le-Gillon, France).
Measurements were performed on native narrow pupil after 10 minutes adaptation in the dark 
(5mm). Values of coma were used as a root mean square (RMS) of quadrant coefficient Z-13 
and Z 13 values addition, trefoil values were used as a root mean square (RMS) of quadrant 
coefficient Z-33 and Z 33 values addition. Values of spherical aberrations were taken as amount 
of Z 04 coefficient.
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4.2.4. SURGICAL TECHNIQUE
Prior to the surgery, two drops of topical anesthetic (Novesine, OmniVision GmbH, Puchheim, 
Germany) were instilled at 2 minute intervals (care should be taken to ensure that the drops are 
not instilled too early, as doing so may loosen the epithelium substantially), and the eye was 
cleaned with 2.5% povidone iodide. First, procedure was performed on the right eye. When it was 
completed, the same procedure was repeated on the left eye. After the patient was positioned 
under the laser, a sterile drape was placed over the upper eyelid skin and eyelashes. An eyelid 
speculum was placed in the eye to be treated, and an opaque patch was placed over the fellow 
eye to avoid cross-fixation. A gauze pad was taped over the temple between the eye to be 
treated and the ear on that side – to absorb any excess fluid. The patient was asked to fixate 
on the green laser centration light. It is important for the plane of the eye to remain parallel to 
the plane of the laser, for the patient to maintain fixation, and for the surgeon to control centration 
even when using lasers with tracking systems (both lasers in this research have eye tracking 
systems). For most patients, voluntary fixation during photoablation produces more accurate 
centration than globe immobilization by the surgeon.
Before creating the flap asymmetric sterile ink marks in the corneal periphery were made, posi-
tioned at 3 and 9 o’clock away from the intended flap hinge. These marks can aid in alignment 
of the flap at the end of the surgery. Eye was fully irrigated with balanced salt solution and the 
excess liquid was dried out afterwards with the Merocel surgical microsponges (Medtronic, 
Jacksonville, FL, USA). A corneal flap was created using Moria M2 mechanical microkeratome 
with	90	μm	head	(Moria,	Antony,	France).	The	microkeratome	was	sterilized	and	assembled	by	
technical personnel and tested by the surgeon before each operation.
After the removal of excess liquid, metal ring of microkeratome was placed on the eye. The 
microkeratome head was engaged into the suction ring and then moved over the cornea with 
a purpose of creating flap with 8,5-9,0 mm in diameter (size of the ring was chosen according 
to the nomogram depending on keratometric values), and then vacuum was applied. When 
adequate vacuum of 150 mm was accomplished, microkeratome motor with previously assembled 
90 µm blade was placed on the ring. Blade of 90 µm is predicted for creation of 110 µm flap 
(during the use of speed 1 on Evolution 3 central unit). With a use of automatic foot pedals, 
microkeratome was driven over the eye with the goal of a superior hinge formation. After the 
flap creation, complete unit – consisted of vacuum ring and motor – was lifted from the eye, and 
inspection of flap quality was performed. Then, with a help of the LASIK spatula flap was lifted 
and moved to 12o’clock position on the superior conjuctiva. Corneal stroma was dried from the 
excess liquid with a triangle microsponge, and excimer laser ablation was applied.
Either Wavelight Allegretto Eye-Q 400 Hz (Alcon, Forth Worth, TX, USA) or Schwind Amaris 
750S (Schwind eye-tech-solutions, Kleinostheim, Germany) were used for the excimer laser 
treatment. Wavelight Allegretto is a scanning spot laser with Gaussian beam profile and beam 
size of 0.95 mm. Average fluence is 200 (mJ/cm²). Schwind Amaris 750S is a scanning spot 
laser with Super Gaussian beam profile and beam size of 0.54 mm. 
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Average fluence is automatic; depending on the planned refractive correction, approximately 
80% of the corneal ablation is performed with a high fluence level (>400 mJ/cm²) and this leads 
to a considerable reduction in time spent treating the cornea. Fine correction is performed for 
the remaining 20% of the treatment using a low fluence level (<200 mJ/cm²), aimed to reduce 
the amount ablated per pulse and smooth out the ablated stromal bed.
In all patients treated with Allegretto Eye-Q laser, the optical zone was fixed at 6.5 mm as 
recommended by the manufacturer, and the wavefront optimized program was used. Since the 
laser ablation algorithm is based on preservation of corneal asphericity by delivering additional 
laser pulses on the periphery to maintain a natural corneal shape, total ablation zones were 
wide; 8.9 for mixed astigmatism and 9.0 mm for myopic astigmatism cases. For the Amaris 
750S, the mean optical zone of the treatment was 6.63±0.20 mm (range 6.5 to 7.0 mm). The 
rationale for changing optical zone was based on the manufacturer’s recommendation to select, 
at least, a 6.7 mm optical zone for treatment of astigmatism. However, the goal was not to exceed 
9.0 mm zone of total ablation. Since the transition zone (automatically calculated by the system 
for the selected optical zone and applied correction) increases with the complexity of the applied 
correction, size of an optical zone was chosen to fit within the limits of 9.0 mm of total ablation 
zone. The total ablation zone was 8.67±0.31 mm (range 7.9 to 9.0 mm). The Aberration FreeTM 
program was applied in all cases. All ablations were centered on corneal vertex for both laser 
platforms. The corneal vertex is the intersection of the papillary axis with the anterior surface 
of the cornea, when the pupillary axis coincides with the optical axis of the measuring device. 175
The position of the corneal vertex was determined by the pupillary offset, that is the distance 
between the pupil center and the normal corneal vertex,176 calculated by using the videokerato-
scope (CSO, Costruzione Strumenti Oftalmici, Florence, Italy) for Amaris, and Scheimpflug 
camera (Pentacam HRTM, Oculus Optikgeräte GmbH, Wetzlar, Germany) for Allegretto. The 
Cartesian coordinates of the corneal vertex were manually entered into the software program. 176
For all patients, the programmed treatment consisted of cycloplegic spherical correction with 
manifest astigmatic power and axis. For the Allegretto Eye-Q, the “Wellington nomogram” 
provided by the company was used for spherical correction. The nomogram also directs the 
surgeon to correct 25% less of the full astigmatism. Previous experience showed that the 25% 
modification led to significant undercorrection. Thus, it was decided to use an empirically derived 
undercorrection of 15% in all cases where the Allegretto Eye-Q was used. For the Amaris 750S 
the sphere, cylinder, and axis were entered into laser without nomogram adjust-ment. Before 
excimer laser ablation, proper alignment of the eye with Allegretto Eye-Q was achieved with a 
manual cross technique to compensate for cyclotorsion. The Allegretto Wave operates with 
closed-loop 3D eye tracker of 400 Hz implyng rate, with automatic pupil centering. It has an 
integrated cross-line projector for alignment of the head and eye position, with a “NeuroTracker” 
for cyclotorsion control for the wavefront-optimized algorithm. Its eye-tracker system and laser 
trigger are synchronized. 177
Schwind Amaris 750S features a six-dimensional 1050 Hz infrared eye tracker with simultaneous 
limbus, pupil, iris recognition, and cyclotorsion tracking integrated in the laser delivery process. 
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The built-in 6D eye tracker automatically compensated for static and dynamic cyclotorsion of 
the eye.
In all cases, the flap was lifted and excimer laser ablation was delivered to the stroma. Patients 
were instructed to concentrate on the fixation light throughout the ablation. When the ablation 
with excimer laser was completed, the eye, specially the interface was irrigated with balanced 
salt solution, removing any debris and flap was repositioned on the stroma. Edges of the flap 
were carefully dried with the use of triangular microsponge. After the final inspection of the flap 
position, combination of antibiotic and steroid drops were instilled into the eye, and the eyelid 
speculum and sterile drape were gently removed.
TABLE 3. The main differences between the two laser platforms
SCHWIND AMARIS 750S WAVELIGHT ALLEGRETTO 400 Hz
Ablation type Scanning spot Scanning spot
Beam profile Super Gaussian Gaussian
Beam size (mm) 0.54 0.95
Average fluence (mJ/cm2) Automatic (faster-slower) 200
Pulse frequency 750 400
Eye tracker implying rate (Hz) 1050 400
Cyclotorsion compensation YESStatic and dynamic NO
Optical zone ADJUSTABLE CONDITIONAL FIXED 6.5mm
4.2.5. POSTOPERATIVE THERAPY
Postoperative therapy included combination of topical antibiotic and steroid drops (Tobradex, 
Alcon, ForthWorth, TX, USA) 4 times daily for 10 days, and artificial tears (Blink, Abbott Medical 
Optics, Santa Ana, CA, USA) 6–8 times daily for at least 1 month.
4.2.6. POSTOPERATIVE EVALUATION
All patients were examined 1 day, 1 week, 1 month, 3 months, and 1 year after the surgery. 
Evaluation included measurement of UDVA, CDVA, manifest refraction, aberrometry, slit-lamp 
examination, tonometry, and corneal topography. Results at 1 year postop were also used to 
perform the vector analysis and statistical evaluation.
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4.2.7. VECTOR ANALYSIS
Astigmatism is measured by its magnitude and axis. These two values must be considered 
together. Consequently, it is difficult to perform even the simpliest statistical analysis of refractive 
data. With that reason vectors were used, they incorporate magnitude and axis, two data into one.
4.2.7.1. THIBOS METHOD
The method 178 implies application of Fourier analysis to describe the sinusoidal variation of 
power in the astigmatic refraction. 178-181
According to this method, astigmatism was converted from the spherocylinder notation (units 
of diopter) to a single point in a 3 – dimensional dioptric space, called power vector notation. 
The first component is a spherical lens with power M equal to the spherical equivalent of the 
given refractive error (S = sphere + cylinder/2). The remaining two components come from a 
Jackson	crossed	cylinder,	equivalent	to	a	conventional	cylinder	of	positive	power	J	at	axis	α	+	90°	
(α	=	the	meridian	of	maximum	positive	power	or	angle	of	astigmatic	prescription)	crossed	with	
a cylinder of negative power -J at axis 90°. Thus, a power vector is that vector drawn from the 
coordinate origin of this space to the point (S, J0, and J45). 
180, 181
The magnitude of the astigmatic power vector (APV) on the astigmatic plane is defined by 
(J0 2 +J45 2) 1/2 and represents a non-signed scalar that may be used to determine statistical 
differences in the magnitude of astigmatism between two datasets. 182-186
J0 refers to cylinder power set at orthogonally 90° and 180° meridians, representing Cartesian 
astigmatism.
Positive values of J0 indicate WTR astigmatism and negative values of J0 indicate ATR astigmatism.
J45 refers to a cross-cylinder set at 45° and 135°, representing oblique astigmatism.
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4.2.7.2. ALPINS METHOD
The Alpins Method, developed by Australian ophthalmologist Noel Alpins, is a system to plan 
and analyse the results of refractive surgical procedures, such as LASIK. 187-189
The Alpins Method uses vector mathematics to determine a goal for astigmatism correction and 
analyse factors involved if treatment fails to reach that goal. The method can also be used to 
refine surgical techniques or correct laser settings in future procedures. 190
The Alpins method is a vectorial analysis that allows determination of the effectiveness of a 
specific astigmatic treatment. It considers both magnitude and orientation of astigmatism. Three 
fundamental vectors are used in the analysis: target-induced astigmatism (TIA) – the astigmatic 
change the surgery was intended to induce, surgically induced astigmatism (SIA) – the astigmatic 
change the surgery actually induced and difference vector (DV) – the induced astigmatic change 
that would enable the initial surgery to achieve its intended target. Various relationships between 
these vectors, such as correction index (SIA/TIA), flattening index ([SIA x Cos 2 x angle between 
SIA and TIA]/TIA), index of success (DV/TIA) among others, provide a complete description of 
the astigmatic correction achieved with a specific modality of treatment. It can be determined 
whether the treatment was on axis, or off axis and whether too much, or too little effect was 
achieved. 190
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4.3. STATISTICAL ANALYSIS
Data were analysed to determine significance of change in spherical correction, astigmatism, 
UDVA, CDVA, high order aberrations, (z-test, 2 – Sample Assuming Unequal Variances for data 
with normal distribution and Mann-Whitney U test for non-parametric analysis) within each group 
and between groups to determine whether there was significant difference between two lasers. 
Changes and differences were considered statistically significant when p<0.05. Spherical 
aberration was further analysed with cluster analysis to see the trend in change.
Data were further analysed with Pearson correlation to determine the significance of any cor-
relation between pre and postoperative sphere, cylinder and visual acuity. Correlations were 
considered significant when p<0.05.
Refractive cylinder data were further analysed with Thibos method. The J0 and J45 vectors were 
calculated for the refractive data collected preop and at 1 year postoperative. Cases were 
separated into 4 groups as follows:
Group 1, myopic astigmatism treated with Allegretto (n=127 eyes)
Group 2, myopic astigmatism treated with Amaris (n=119 eyes)
Group 3, mixed astigmatism treated with Allegretto (n=61 eyes)
Group 4, mixed astigmatism treated with Amaris (n=111 eyes)
The data were analysed to determine the significance of any:
1. Difference in the means between the two groups of myopic astigmatic cases both before and 
after treatment according to the two astigmatic vectors J0, and J45 (t test).
2. Difference in the means between the two groups of mixed astigmatic cases both before and 
after treatment according to the two astigmatic vectors J0, and J45 (t test).
3.	 Correlation	between	the	change	(Δ)	in	each	astigmatic	vector	(J0 and J45) and pretreatment 
astigmatic vector value within each of the four groups (Pearson correlation) and apparent 
difference between the two correlation coefficients, for each of the two platforms, within four 
groups (Fischer’s ‘r’ to ‘z’ transformation).
4. Association between J0 and J45 vectors before and after treatment within each of the 4 groups 
(Pearson correlation).
The null hypothesis was rejected when p exceeded 0.01.
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In addition, refractive cylinder data were also analysed with Alpins method.
The data were analysed as follows:
1. To determine if the surgically induced astigmatic power and axis was significantly correlated 
with the target induced astigmatic power (Pearson correlation coefficient, r multiple linear 
regression).
2. To determine if the surgically induced astigmatic axis was significantly correlated with the 
target induced astigmatic power and axis (Pearson correlation coefficient, r multiple linear 
regression).
3.	 To	determine	the	significance	of	any	association	between	ΔC	(the	difference	between	the	
surgically induced astigmatic power minus the target induced astigmatic power) and the 
target induced astigmatic power.
4.	 To	determine	the	significance	of	any	association	between	Δθ	(the	difference	between	the	
surgically induced astigmatic axis minus the target induced astigmatic axis) and the target 
induced astigmatic axis.
5.	 To	determine	the	significance	of	any	apparent	differences	of	average	Δθ	values	between	
platforms.
The significance level was set at a p<0.05.
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4.4. ETHICAL ASPECTS OF RESEARCH
Described research assured compliance of basic ethical and bioethical principles – personal 
integrity (autonomy), equity, benevolence and safety – in accordance with Nurnberg code and 
newest revision of the tenets of the Helsinki agreement. Medical data was collected according 
to ethical and bioethical principles, and privacy of the patients included in research (medical 
secret) was assured together with secrecy.
The study was approved by the Ethics Committee of University Eye Hospital Svjetlost Zagreb, 
Croatia. All patients signed detailed preoperative informed consent after they received an 
explanation of the procedure, including all risks and benefits of the proposed treatment together 
with possibilities of other, including non-surgical, astigmatism treatments.
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5. RESULTS
5.1. VISUAL ACUITY
5.1.1. MYOPIC ASTIGMATISM
There was no statistically significant difference (p>0.05) in preoperative UDVA and CDVA 
between the patients from group 1 – Myopic astigmatism corrected with Wavelight Allegretto 
Eye-Q or group 2 – Myopic astigmatism corrected with Schwind Amaris 750S platform.
TABLE 4. Visual results of group 1 – Myopic astigmatism corrected with Wavelight Allegretto Eye-Q platform
Visual results – myopic astigmatism
Wavelight Allegretto Eye-Q
Variable Mean±standard deviation (range)
Preop Postop p value*
UDVA 0.15±0.15 (0.01 to 0.70) 0.86±0.16 (0.35 to 1.00) <0.001
CDVA 0.81±0.17 (0.30 to 1.00) 0.89±0.16 (0.40 to 1.00) <0.001
In the group 1, there was a statistically significant improvement in both postoperative UDVA and 
CDVA in comparison to preoperative results. (Table 4)
Values of postoperative UDVA showed improvement in comparison to preoperative CDVA. The 
difference was equivalent to half a line of Snellen letters and this was statistically significant 
(p=0.017). None of the eyes lost any lines of CDVA.
TABLE 5. Visual results of group 2 – Myopic astigmatism corrected with Schwind Amaris 750S platform
Visual results – myopic astigmatism
Schwind Amaris 750S
Variable Mean±standard deviation (range)
Preop Postop p value*
UDVA 0.13±0.11 (0.01 to 0.45) 0.86±0.19 (0.15 to 1.00) <0.001
CDVA 0.81±0.18 (0.10 to 1.00) 0.89±0.20 (0.40 to 1.00) 0.001
In the group 2, there was a statistically significant improvement in both postoperative UDVA and 
CDVA in comparison to preoperative results. (Table 5)
Values of postoperative UDVA appear to show an improvement in comparison to preoperative CDVA.
The difference was not statistically significant (p=0.06). None of the eyes lost any lines of CDVA.
There was no difference in postoperative UDVA or CDVA between lasers for myopic astigmatism 
(p>0.05).
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5.1.2. MIXED ASTIGMATISM
There was no statistically significant difference (p>0.05) in preoperative UDVA and CDVA between 
the patients from group 3 – Mixed astigmatism corrected with Wavelight Allegretto Eye-Q and 
patients from group 4 – Mixed astigmatism corrected with Schwind Amaris 750S platform.
TABLE 6. Visual results of group 3 – Mixed astigmatism corrected with Wavelight Allegretto Eye-Q platform
Visual results – mixed astigmatism
Wavelight Allegretto Eye-Q
Variable Mean±standard deviation (range)
Preop Postop p value*
UDVA 0.25±0.14 (0.03 to 0.60) 0.77±0.20 (0.20 to 1.00) <0.001
CDVA 0.74±0.22 (0.15 to 1.00) 0.82±0.21 (0.20 to 1.00) 0.04
In the group 3 there was a statistically significant improvement in both postoperative UDVA and 
CDVA in comparison to preoperative results. (Table 6)
Values of postoperative UDVA appear to show an improvement in comparison to preoperative 
CDVA but this was not statistically significant (p>0.05). None of the eyes lost any lines of CDVA.
TABLE 7. Visual results of group 4 – Mixed astigmatism corrected with Schwind Amaris 750S platform
Visual results – mixed astigmatism
Schwind Amaris 750S
Variable Mean±standard deviation (range)
Preop Postop p value*
UDVA 0.24±0.12 (0.02 to 0.60) 0.80±0.21 (0.05 to 1.00) <0.001
CDVA 0.77±0.20 (0.04 to 0.95) 0.85±0.21 (0.10 to 1.00) 0.04
In the group 4, there was a statistically significant improvement in both postoperative UDVA and 
CDVA in comparison to preoperative results. (Table 7)
Values of postoperative UDVA show an improvement in comparison to preoperative CDVA. The 
difference was not statistically significant (p>0.05). None of the eyes lost any lines of CDVA.
There were no differences between UDVA and CDVA for mixed astigmatism.
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5.2. REFRACTIVE RESULTS
5.2.1. MYOPIC ASTIGMATISM
There was no statistically significant difference (p>0.05) in preoperative sphere or cylinder 
between the patients from group 1 – Myopic astigmatism corrected with Wavelight Allegretto Eye-Q 
and patients from group 2 – Myopic astigmatism corrected with Schwind Amaris 750S platform.
TABLE 8. Refractive results of group 1 – Myopic astigmatism corrected with Wavelight Allegretto Eye-Q 
platform
Refractive results - myopic astigmatism
Wavelight Allegretto Eye-Q
Variable Mean±standard deviation (range)
Preop Postop p value*
UDVA -2.80±2.01 (-8.50 to 0.00) -0.16±0.46 (-1.50 to +1.00) <0.001
CDVA -3.30±1.00 (-7.50 to -2.00) -0.55±0.46 (-2.25 to 0.00) <0.001
In the group 1, average sphere decreased from −2.80 D to −0.16 D (p<0.001), and average 
cylinder decreased from −3.30 D to −0.55 D (p<0.001).
There was a statistically significant shift towards zero (i.e. emmetropia) in both postoperative 
sphere and cylinder in comparison to preoperative values.
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FIGURE 12. Attempted vs. achieved cylinder correction of group 1 – Myopic astigmatism corrected with 
Allegretto Eye-Q platform
Attempted vs achieved cylinder correction (D) in myopic astigmatism corrected with Allegretto 
Eye-Q. The least-squares regression line, best-fit linear equation and R2 are included for 
comparison with Figures 13, 14, & 15.
There was a highly significant association between the attempted and achieved astigmatic 
correction (R2=0.7874).
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TABLE 9. Refractive results of group 2 – Myopic astigmatism corrected with Schwind Amaris 750S platform
Refractive results – myopic astigmatism
Scwind Amaris 750S
Variable Mean±standard deviation (range)
Preop Postop p value*
UDVA -2.44±2.17 (-7.50 to 0.00) -0.16±0.55 (-2.00 to +1.25) <0.001
CDVA -3.21±0.87 (-6.50 to -2.00) -0.43±0.36 (-1.50 to 0.00) <0.001
In	the	group	2,	average	sphere	decreased	from	−2.44	D	to	−0.16	D	(p<0.001) and average 
cylinder	decreased	from	−3.21	D	to	−0.43	D	(p<0.001).
There was a statistically significant improvement, shift towards zero (i.e. emmetropia) in both 
postoperative sphere and cylinder when comparing to preoperative values of sphere and cylinder.
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FIGURE 13. Attempted vs. achieved cylinder correction of group 2 – Myopic astigmatism corrected with 
Schwind Amaris 750S platform
Attempted vs. achieved cylinder correction (D) in myopic astigmatism corrected with Amaris 
750S. The least-squares regression line, best-fit linear equation and R2 are included for 
comparison with Figures 12, 14 & 15.
For the myopic astigmatism treated with Amaris platform there was a highly significant association 
between the attempted and achieved astigmatic correction (R2=0.8335).
There was no difference in effectiveness of spherical correction between laser platforms 
(p=0.969). There was a significant difference in effectiveness of cylinder correction between 
the groups (p=0.027). In the group 1, there was a tendency toward residual cylinder when 
comparing the attempted cylindrical correction with the postoperative cylinder (r=0.3978, p<0.01, 
n=127). The group 2 had less residual astigmatism than the group 1, and the difference was 
significant (p=0.027). The attempted and achieved astigmatic corrections revealed highly 
significant association between the attempted and achieved astigmatic corrections. (Figure 12 
and Figure 13)
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5.2.2. MIXED ASTIGMATISM
There was no statistically significant difference (p>0.05) in preoperative sphere or cylinder 
between the group 3 – patients corrected with Wavelight Allegretto Eye-Q and group 4 – patients 
corrected with Schwind Amaris 750S platform.
TABLE 10. Refractive results of group 3 – Mixed astigmatism corrected with Wavelight Allegretto Eye-Q 
platform
Refractive results - mixed astigmatism
Wavelight Allegretto Eye-Q
Variable Mean±standard deviation (range)
Preop Postop p value*
UDVA 2.72±1.79 (0.25 to 7.00) 0.19±0.52 (-1.50 to +1.50) <0.001
CDVA 3.84±1.21 (-6.50 to -2.00) -0.85±0.41 (-2.00 to 0.00) <0.001
In the group 3, average sphere decreased from +2.72 D to +0.19 D (p<0.001). Average cylinder 
decreased from −3.84 D to −0.85 D (p<0.001).
There was a statistically significant shift towards zero (i.e. emmetropia) in both postoperative 
sphere and cylinder in comparison to preoperative values of sphere and cylinder.
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FIGURE 14. Attempted vs. achieved cylinder correction of group 3 – Mixed astigmatism corrected with 
Wavelight Allegretto Eye-Q platform
Attempted vs. achieved cylinder correction (D) in mixed astigmatism corrected with Allegretto 
Eye-Q. The least-squares regression line, best-fit linear equation and R2 are included for 
comparison with Figures 12, 13 & 15.
For the mixed astigmatism cases treated with Wavelight Allegretto Eye-Q there was a highly 
significant association between the attempted and achieved astigmatic correction (R2=0.8894).
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TABLE 11. Refractive results of group 4 – Mixed astigmatism corrected with Schwind Amaris 750S platform
Refractive results – mixed astigmatism
Scwind Amaris 750S
Variable Mean±standard deviation (range)
Preop Postop p value*
UDVA 3.11±1.57 (+0.50 to +7.50) 0.28±0.45 (-0.75 to +1.00) <0.001
CDVA -3.66±1.16 (-7.00 to -2.00) -0.58±0.38 (-1.50 to 0.00) <0.001
In the group 4, average sphere decreased from +3.11 D to +0.28 D (p<0.001) and average 
cylinder	decreased	from	−3.66	D	to	−0.58	D	(p<0.001).
There was a statistically significant shift towards zero (i.e. emmetropia) in both postoperative 
sphere and cylinder comparing to preoperative values of sphere and cylinder for mixed 
astigmatism treated with Amaris laser platform.
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FIGURE 15. Attempted vs. achieved cylinder correction of group 4 – Mixed astigmatism corrected with 
Schwind Amaris 750S platform
Attempted vs achieved cylinder correction (D) in mixed astigmatism corrected with Amaris 750S. 
The least-squares regression line, best-fit linear equation and R2 are included for com-parison 
with Figures 12,13 & 14.
For the Amaris 750s laser platform there was a highly significant association between the attempted 
and achieved astigmatic correction (R2=0.8805).
There was no difference in effectiveness of spherical correction between laser platforms 
(p=0.236). There was a significant difference in effectiveness of cylinder correction between 
the groups (p<0.001). For the group 3, there was a tendency toward residual cylinder when 
comparing the attempted cylindrical correction with the postoperative cylinder (r=0.4567, p<0.01, 
n=61). The group 4 had less residual astigmatism than the group 3, and the difference was 
significant (p<0.001). The attempted and achieved astigmatic corrections revealed highly 
significant association between the attempted and achieved astigmatic corrections. (Figure 14 
and Figure 15)
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5.3. VECTOR ANALYSIS OF REFRACTIVE RESULTS
5.3.1. THIBOS METHOD
5.3.1.1. MYOPIC ASTIGMATISM
There was no statistically significant difference in preoperative mean values for J0 and J45 
between the groups (p=0.150, p=0.289) 1 and 2.
TABLE 12. Comparison of platforms for the J0 and J45 vector (groups 1 and 2)
Preop J0 Postop J0 P Preop J45 Postop J45 P
mean (± SD) mean (± SD) mean (± SD) mean (± SD)
Wavelight Allegretto Eye-Q +1.369±0.776 +0.092±0.276 <0.001 +0.076±0.695 −0.058±0.204 0.042
Schwind Amaris 750S +1.221±0.832 +0.065±0.202 <0.001 −0.023±0.769 +0.005±0.184 0.685
Comparison of platforms p*=0.150 p*=0.380 p*=0.289 p*=0.012
The J0 and J45 vectors are defined in 4.2.7.1. in Methods section. The units of these vectors 
include trigonometric functions of angles (°) and dioptral power (D).
There was a statistically significant difference between J0 preop and J0 postoperatively for both 
platforms (p<0.001). There was no statistically significant difference for J0 postoperatively 
between the platforms (p=0.380). There was no statistically significant difference between J45 
preop and J45 postoperatively for either platform (p=0.042 and 0.685 for the Allegretto and 
Amaris groups respectively). There was a statistically significant difference for J45 postoperatively 
between the platforms (p=0.012). (Table 12)
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FIGURE 16.	Correlation	between	ΔJ0 and preoperative J0 values – comparison of platforms (groups 1 and 2)
Comparison	of	the	difference	(Δ)	between	the	pre-	and	postoperative	J0 vector values with 
preoper-ative J0	values.	The	least	squares	regression	lines	equating	ΔJ0 and preoperative J0 
were as follows:
Group	1,	ΔJ0=0.924	ΔJ0+0.190 (r=0.936, n=127, p<0.001).
Group	2,	ΔJ0=1.019	ΔJ0+0.041 (r=0.971, n=119, p<0.001).
The	difference	between	these	two	correlation	coefficients	was	significant	(z=−3.086,	p=0.002).
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FIGURE 17.	Correlation	between	ΔJ45 and preoperative J45 values – comparison of platforms (groups 1 and 2)
Comparison	of	the	difference	(Δ)	between	the	pre-	and	postoperative	J45 vector values with 
preoperative J45	values.	The	least	squares	regression	lines	equating	ΔJ45 and preoperative J45 
were as follows:
Group	1,	ΔJ45=0.905	ΔJ45 -0.046 (r=0.961, n=127, p<0.001).
Group	2,	ΔJ45=1.009	ΔJ45+0.009 (r=0.971, n=119, p<0.001).
The difference between these two correlation coefficients was not significant (z=-1.13, p=0.259).
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FIGURE 18. Association between pre- and postoperative values of J0 and J45 for Wavelight Allegretto 
Eye-Q platform (group 1)
In	the	group	1,	preoperative	r=−0.158	(p=0.076)	and	postoperative	r=−0.197	(p=0.026). Vector 
values are converging towards zero, but they are not zero. Treatments are working to nullify 
astigmatism but they don’t cancel it out completely. Some residual astigmatism is still present 
after the surgery.
FIGURE 19. Association between pre- and postoperative values of J0 and J45 for Amaris 750 S platform 
(group 2)
In the group 2, preoperative r=0.126 (p=0.172) and postoperative r=0.0904 (p=0.328). Vector 
values are converging towards zero, but they are not completely on the zero point. Some amount 
of residual astigmatism is still present after the surgery, so the treatments don’t nullify all amount 
of astigmatism.
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5.3.1.2. MIXED ASTIGMATISM
There was a statistically significant difference in preoperative mean values for J0 (p<0.001) 
while there was no statistically significant difference in preoperative mean values for J45 (p=0.528) 
between the groups 3 and 4.
TABLE 13. Comparison of platforms for the J0 and J45 vector (groups 3 and 4)
Preop J0
mean (± SD)
Postop J0
mean (± SD)
P Preop J45
mean (± SD)
Postop J45
mean (± SD)
P
Wavelight Allegretto Eye-Q +1.417±1.198 +0.108±0.359 <0.001 −0.120±0.782 −0.039±0.285 0.424
Schwind Amaris 750S +0.609±1.581 +0.064±0.268 <0.001 −0.036±0.916 −0.031±0.209 0.955
Comparison of platforms p*<0.001 p*=0.402 p*=0.528 p*=0.863
The J0 and J45 vectors are defined in 4.2.7.1. in Methods section. The units of these vectors 
include trigonometric functions of angles (°) and dioptral power (D).
There was a statistically significant difference between J0 preop and J0 postoperatively for both 
platforms (p<0.001). There was no statistically significant difference for J0 postoperatively 
between the platforms (p=0.402). There was no statistically significant difference between J45 
preop and J45 postoperatively for either platform (p=0.424 and 0.955 for the group 3 and group 
4 respectively). There was no statistically significant difference for J45 postoperatively between 
the platforms (p=0.863). (Table 13)
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FIGURE 20.	Correlation	between	ΔJ0 and preop J0 values – comparison of platforms (groups 3 and 4)
Comparison	of	the	difference	(Δ)	between	the	pre-	and	postoperative	J0 vector values with 
preoperative J0	values.	The	least	squares	regression	lines	equating	ΔJ0 and preoperative J0 
were as follows:
Group	3,	ΔJ0 = 0.955 J0 + 0.168 (r=0.955, n=61, p<0.001).
Group	4,	ΔJ0 = 0.999 J0 + 0.065 (r=0.986, n=111, p<0.001).
The	difference	between	these	two	correlation	coefficients	was	significant	(z=−3.533,	p=0.0004).
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FIGURE 21.	Correlation	between	ΔJ45 and preop J45 values – comparison of platforms (groups 3 and 4)
Comparison	of	the	difference	(Δ)	between	the	pre-	and	postoperative	J45 vector values with 
preoperative J45	values.	The	least	squares	regression	lines	equating	ΔJ45 and preoperative J45 
were as follows:
Group	3,	ΔJ45 = 0.926 J45 + 0.045 (r=0.934, n=61, p<0.001).
Group	4,	ΔJ45 = 1.020 J45 + 0.032 (r=0.974, n=111, p<0.001).
The	difference	between	these	two	correlation	coefficients	was	significant	(z=−2.886,	p=0.004).
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FIGURE 22. Association between pre- and postoperative values of J0 and J45 for group 3 – Mixed astigmatism 
corrected with Wavelight Allegretto Eye-Q platform.
In the group 3, preoperative r=0.238 (p=0.065)	and	postoperative	r=−0.028	(p=0.833). 
Treatments are working to nullify astigmatism (vector values are converging towards zero) but 
they don’t achieve it completely.
FIGURE 23. Association between pre- and postoperative values of J0 and J45 for group 4 – Mixed astigmatism 
corrected with Amaris 750 S platform
In the group 4, preoperative r=0.104 (p=0.277) and postoperative r=0.030 (p=0.754). Vector values 
are converging towards zero, but they are not zero. Treatments are working very good, but not 
excellent, because still some residual astigmatism is still present postoperatively.
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5.3.2. ALPINS METHOD
5.3.2.1. MYOPIC ASTIGMATISM
FIGURE 24. Comparison of target induced astigmatism and surgically induced astigmatism for group 1 – 
Myopic astigmatism corrected with Allegretto Eye-Q platform
These are polar diagrams where TIA (filled circles) and SIA (unfilled circles) data are compared. 
The values along x-axis are negative. There are more unfilled circles inside the 2.00 D semicircle 
than filled circles. This points toward undercorrection of astigmatism.
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FIGURE 25. Comparison of target induced astigmatism and surgically induced astigmatism for group 2 – 
Myopic astigmatism corrected with Amaris 750S platform
In these polar diagrams TIA (filled circles) and SIA (unfilled circles) data are compared, and the 
values along x-axis are negative. Inside the 2.00 D there are more unfilled than filled circles 
that indicates undercorrection of astigmatism.
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FIGURE 26. Ratio of surgically induced /target induced astigmatic power and the intended axis of astigmatic 
correction for group 1 – Myopic astigmatism corrected with Allegretto platform (group 1)
This polar diagram is showing the ratio of the TIA and SIA in relation to the intended axis of 
astigmatic correction. The horizontal x-axis represents the ratio ranging from 0 to up to 1.8 from 
the center outward in 0.2 steps. The loci of the most data points occur between the 0.6 and 1.2 
ratios. The filled circles are the loci where the ratios equal one. Ideally, all data points should 
lie on the ‘1.0’ semicircle.
Multiple linear regression analysis revealed significant association between the SIA power (y1), 
sine of the axis (y2), TIA power (x1), and sine of the axis (x2). The equations are following:
y1=0.829x1-0.403x2-0.325 (r =0.804, p<0.001, rpower = 0.799, ppower = <0.001, raxis = 0.074, paxis=0.466)
y2=0.951x2-0.007x1+0.008 (r =0.950, p<0.001, rpower = 0.008, ppower = 939, raxis = 0.950, paxis<0.001)
76
Prospective comparison of two excimer laser platforms in treatment of high astigmatism with laser in situ keratomileusis
FIGURE 27. Ratio of surgically induced / target induced astigmatic power and the intended axis of 
astigmatic correction for group 2 – Myopic astigmatism corrected with Amaris 750S platform
The ratio of the TIA and SIA in relation to the intended axis of astigmatic correction is showed 
on this polar diagram. The loci of the most data points take place between the 0.6 and 1.2 ratios 
on horizontal x-axis, where the ratio is ranging from 0 to up to 1.8 from the center outward in 
0.2 steps. The filled circles are the loci where the ratios equal one. Ideally, all data points should 
be located on the ‘1.0’ semicircle.
Multiple linear regression analysis revealed significant association between the SIA power (y1), 
sine of the axis (y2), TIA power (x1), and sine of the axis (x2). The equations are following:
y1=0.891x1-0.039x2-0.192 (r=0.897, p<0.001, rpower = 0.897, p power = <0.001, r axis = 0.060, paxis=0.521)
y2=0.856x2-0.007x1+0.105 (r=0.832, p<0.001, rpower = 0.092, p power = 0.329, r axis = 0.074, paxis<0.001)
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FIGURE 28. Comparison of surgically induced and target induced astigmatic powers for group 1 – Myopic 
astigmatism corrected with Allegretto Eye-Q platform
FIGURE 29. Comparison of surgically induced and target induced astigmatic powers for group 2 – Myopic 
astigmatism corrected with Amaris 750S platform
Figures 28 and 29 compare the TIA and SIA powers. The solid line represents the surgically 
induced = target induced astigmatic power. Most data points are below the one-to-one line 
which points toward undercorrection of astigmatism.
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5.3.2.2. MIXED ASTIGMATISM
FIGURE 30. Comparison of surgically induced astigmatism and target induced astigmatism for group 3 – 
Mixed astigmatism corrected with Allegretto Eye-Q platform
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FIGURE 31. Comparison of surgically induced astigmatism and target induced astigmatism for group 4 – 
Mixed astigmatism corrected with Amaris 750S platform
Surgically induced astigmatism (SIA) and target induced astigmatism (TIA) are defined in 4.2.7.2. 
in Methods section.
Figures 30 and 31 are polar diagrams where SIA (unfilled circles) and TIA (filled circles) data 
are compared, and the values along x-axis are negative. Because there are more unfilled circles 
inside the 2.00 D semicircle than filled circles it points toward undercorrection of astigmatism.
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FIGURE 32. Ratio of surgically induced /target induced astigmatic power and the intended axis of group 3 – 
Mixed astigmatism corrected with Allegretto Eye-Q platform
Polar diagram is showing the ratio of the SIA and TIA in relation to the intended axis of astigmatic 
correction. The horizontal x-axis represents the ratio ranging from 0 to up to 1.8 from the center 
outward in 0.2 steps. The loci of the most data points occur between the 0.6 and 1.2 ratios. The 
filled circles are the loci where the ratios equal one. Ideally, all data points should lie on the ‘1.0’ 
semicircle.
Multiple linear regression analysis revealed significant association between the SIA power (y1), 
sine of the axis (y2), TIA power (x1), and sine of the axis (x2). The equations are following:
y1=1.063x1-0.233x2-0.411 (r=0.881, p<0.001, rpower = 0.880, p power <0.001, raxis = 0.239, paxis = 0.076)
y2=0.953x2-0.009x1+0.075 (r=0.963, p<0.001, rpower = 0.256, p power =0.053, raxis = 0.962, paxis<0.001)
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FIGURE 33. Ratio of surgically induced /target induced astigmatic power and the intended axis of group 4 – 
Mixed astigmatism corrected with Amaris 750S platform
Polar diagram has the same characteristics as in the previous figure (Figure 32) showing the 
ratio of the SIA and TIA in relation to the intended axis of astigmatic correction.
Multiple linear regression analysis revealed significant association between the SIA power (y1), sine 
of the axis (y2), TIA power (x1), and sine of the axis (x2). The equations are following:
y1=1.029x1-0.115x2-0.322 (r=0.908, p<0.001, rpower = 0.907, ppower <0.001, raxis = -0.013, paxis= 0.811)
y2=0.977x2-0.004x1+0.002 (r=0.990, p<0.001, rpower = -0.010, ppower = 0.91, raxis = 0.990, paxis<0.001)
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FIGURE 34. Comparison of surgically induced and target induced astigmatic powers for group 3 – Mixed 
astigmatism corrected with Allegretto Eye-Q platform
FIGURE 35. Comparison of surgically induced and target induced astigmatic powers for group 4 – Mixed 
astigmatism corrected with Amaris 750S platform
Figures 34 and 35 compare the SIA and TIA powers of mixed astigmatism groups. The solid 
line represents the surgically induced = target induced astigmatic power. Most data points are 
below the solid line which points toward undercorrection of astigmatism.
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FIGURE 36.	Average	Angle	of	Error	(Δθ)	for	each	of	the	four	groups
Figure 36 is a histogram showing the average angle of error (angle between the surgically 
induced astigmatism and target induced astigmatism – SIA minus TIA axis). The y-axis is the 
difference in degrees where a negative value indicates a clockwise rotational error and a posi-
tive value indicates the opposite. The ‘T’ bars are the upper positive standard deviation values.
The	mean±standard	deviation	(SD)	values	for	Δθ	(difference	between	the	SIA	axis	minus	TIA	
axis) were -1.22°±4.17° for group 1 – Myopic astigmatism treated with Wavelight Allegretto 
Eye-Q, +0.80°±8.64° for group 2 – Myopic astigmatism treated with Schwind Amaris 750S, 
-0.96°±7.90° for group 3 – Mixed astigmatism treated with Wavelight Allegretto Eye-Q, 
and+0.15°±6.79° for group 4 – Mixed astigmatism treated with Schwind Amaris 750S.
Only the difference between group 1 – Myopic astigmatism treated with Wavelight Allegretto 
Eye-Q and group 2 – Myopic astigmatism treated with the Schwind Amaris 750S was revealed 
to be significant (p=0.020).
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TABLE 14.
SIA Power and Axes Predicted Using the Multilinear Regression Equations
Group a F R P N r power p power r axis p axis
Group 1 (myopic astigmatism corrected with Allegretto Eye-Q)
y1=0.829x1-0.403x2-0.325 87.76 0.804 <0.001 127 0.799 <0.001 0.074 0.466
y2=0.951x2-0.007x1+0.008 446.58 0.950 <0.001 127 0.008 0.939 0.950 <.001
Group 2 (myopic astigmatism corrected with Amaris 750S)
y1=0.891x1-0.039x2-0.192 230.39 0.897 <.001 119 0.897 <0.001 0.060 0.521
y2=0.856x2+0.007x1+0.105 277.35 0.832 <.001 119 0.092 0.329 0.912 <.001
Group 3 (mixed astigmatism corrected with Allegretto Eye-Q)
y1=1.063x1+0.233x2+0.411 990.09 0.881 <.001 61 0.880 <0.001 0.239 0.076
y2=0.953x2+0.009x1+0.075 362.60 0.963 <.001 61 0.256 0.053 0.962 <.001
Group 4 (mixed astigmatism corrected with Amaris 750S)
y1=1.029x1-0.115x2+0.322 270.12 0.908 <.001 111 0.907 <.001 -0.013 0.811
y2=0.977x2+0.004x1+0.002 2.910.90 0.990 <.001 111 -0.010 0.91 0.990 <.001
SIA=surgically induced astigmatism
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5.4. HIGH ORDER ABERRATIONS RESULTS
There was no statistically significant difference (p>0.05) in preoperative higher order aberrations 
coma, trefoil and spherical aberration (SA) between the group 1 – myopic astigmatism corrected 
with Wavelight Allegretto Eye-Q and group 2 – myopic astigmatism corrected with Schwind Amaris 
750S platform.
5.4.1. MYOPIC ASTIGMATISM
TABLE 15. High order aberrations on 5mm pupil of group 1 – Myopic astigmatism corrected with Allegretto 
Eye-Q platform
High-order aberrations — myopic astigmatism
Wavelight Allegretto Eye-Q
Variable Mean±standard deviation
Preop Postop p value*
coma (μm) 0.12±0.09 (0.01 to 0.53) 0.11±0.10 (0.01 to 0.90) 0.592
trefoil (μm) 0.11±0.06 (0.01 to 0.32) 0.11±0.13 (0.01 to 0.90) 0.999
SA (μm) −0.02±0.07	(−0.28	to	0.20) 0.00±0.05	(−0.40	to	0.22) 0.056
There was no significant change between preoperative and postoperative high-order aberrations. 
Although there was no difference in SA between preoperative and postoperative values, SA 
showed a tendency to shift towards more positive values in 54.4% of eyes, and in 42.4% of eyes 
showed a tendency to shift towards negative values, while 3.2% of eyes remained unchanged.
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TABLE 16. High order aberrations on 5mm pupil of group 2 – Myopic astigmatism corrected with Amaris 
750S platform
High-order aberrations — myopic astigmatism
Schwind Amaris 750S
Variable Mean±standard deviation
Preop Postop p value*
coma (μm) 0.11±0.08 (0.00 to 0.40 0.13±0.11 (0.01 to 0.80) 0.166
trefoil (μm) 0.10±0.06 (0.01 to 0.29) 0.09±0.08 (0.01 to 0.49) 0.211
SA (μm) −0.01±0.05	(−0.23	to	0.10) −0.01±0.07	(−0.26	to	0.14) 0.504
There was no significant change between preoperative and postoperative high-order aberrations. 
There was no difference in SA between preoperative and postoperative values, but SA shifted 
towards more positive values in 41.5% of eyes, in 50.0% towards negative values, and in 8.5% 
of eyes remained unchanged.
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5.4.2. MIXED ASTIGMATISM
TABLE 17. High order aberrations on 5mm pupil of group 3 – Mixed astigmatism corrected with Allegretto 
Eye-Q platform
High-order aberrations — mixed astigmatism
Wavelight Allegretto Eye-Q
Variable Mean±standard deviation
Preop Postop p value*
coma (μm) 0.12±0.08 (0.02 to 0.45) 0.10±0.06 (0.04 to 0.28) 0.347
trefoil (μm) 0.13±0.13 (0.01 to 0.90) 0.10±0.05 (0.02 to 0.26) 0.116
SA (μm) 0.02±0.06	(−0.11	to	0.14) 0.00±0.04(−0.09	to	0.12) 0.03
There was no significant change in coma and trefoil, while spherical aberration shifted from 
positive to negative values. SA showed a tendency to shift towards negative values in 63.3% 
of eyes, and in 26.7% of eyes showed a tendency to shift towards more positive values, while 
10.0% of eyes remained unchanged.
TABLE 18. High order aberrations on 5mm pupil of group 4 – Mixed astigmatism corrected with Amaris 
750S platform
High-order aberrations — mixed astigmatism
Schwind Amaris 750S
Variable Mean±standard deviation
Preop Postop p value*
coma (μm) 0.12±0.09 (0.01 to 0.46) 0.11±0.03 (0.01 to 0.53) 0.420
trefoil (μm) 0.10±0.07 (0.01 to 0.44) 0.09±0.08 (0.01 to 0.76) 0.404
SA (μm) 0.02±0.05	(−0.07	to	0.20) 0.00±0.04	(−0.18	to	0.10) <0.001
Spherical aberration shifted from positive to negative values while there was no significant 
change in coma and trefoil. SA showed a tendency to shift towards negative values in 66.1% of 
eyes, in 29.4% of eyes showed a tendency to shift towards more positive values, in 4.5% of 
eyes remained unchanged.
There was no significant difference in the magnitude of high-order aberrations between the 
lasers for mixed astigmatism (coma p=0.222, trefoil p=0.314, SA p=1.00).
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6. DISCUSSION
Laser in situ keratomileusis (LASIK) is regarded as the most performed elective procedure in 
medicine. It is estimated that almost 1,000,000 people per year have a LASIK procedure in the 
USA. 189, 190
Causes of LASIK popularity are based on various factors – no postoperative pain, fast recovery 
of visual acuity, refractive predictability and acuracy, and minimal incidence of intraoperative 
and postoperative complications. 191, 192-195
LASIK is a highly successful surgical treatment for correcting myopia and low levels of hyperopia. 
However, treatment of astigmatism, especially hyperopic astigmatism, is still a therapeutic 
challenge and often results in significant refractive misscorrections. 196, 197
Correcting astigmatism accurately with any refractive procedures is still a challenge. Refractive 
surprises following LASIK for astigmatism may stem from a variety of sources such as, an error 
in the preoperative refraction, keying in the wrong correction into the laser delivery program, 
misorientation of the ablating beam relative to the exact axis of astigmatism, lack of adequate 
consistency in the energy distribution within the photoablating beam, unexpected shifts in corneal 
bulk distribution during the postoperative healing period affecting the topography of corneal optical 
interfaces, errors in postoperative refraction. Sources of error may be self-limiting, some maybe 
accumulative and others may cancel each other out.
Patients with high astigmatism pose a particular challenge in refractive laser surgery because 
the treatment has a lower predictability and, possibly, stability. Laser ablation of high astigmatism 
is technically more demanding due to the alignment of the elliptic ablation axis and the 
compensation for cyclorotation and coupling effect of the sphere component. 198-202
Recent advances in excimer laser technology, such as the use of aspheric ablation profiles, 
incorporation of higher-order aberration treatment, and eye trackers, have presumably led to 
better refractive outcomes and reduced induction of higher-order aberrations postoperatively. 203
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6.1. VISUAL ACUITY
Overcorrection, undercorrection, and residual or induced astigmatism are commonly noted after 
LASIK. 202, 203
Although unpredictable wound healing and corneal biomechanical changes 204 are thought to 
underlie corrections that deviate from the preoperative plan in most cases, the specific aetiology 
is not clear.
Uncorrected distance visual acuity (UDVA) is one of the most important parameters in estimat-
ing the success of a LASIK procedure. UDVA is directly linked with residual refractive error, and 
it is especially important when it comes to evaluation of astigmatic excimer laser ablations, when 
the residual astigmatism is actually expected in some patients. Loss of lines of corrected visual 
acuity are not uncommon. This can be associated with the biomechanical response of the 
cornea following treatment coupled with the exact properties of the astigmatic ablation profile 
and the effective optical zone of the cornea that was photoablated.
For group 1 – myopic astigmatism corrected with Allegretto values of postoperative UDVA 
showed improvement in comparison to preoperative CDVA, the difference was 0.5 Snellen lines 
and was statistically significant (p=0.017).
For group 2 – myopic astigmatism corrected with Amaris 750S improvement in postoperative 
UDVA in comparison to preoperative CDVA was 0.5 Snellen line and was not statistically 
significant (p=0.06).
For group 3 – mixed astigmatism corrected with Allegretto, the values of postoperative UDVA 
showed improvement in comparison to preoperative CDVA, the difference was 0.3 Snellen lines 
and was not statistically significant (p=0.406).
For group 4 – mixed astigmatism corrected with Amaris 750S – improvement in postoperative 
UDVA in comparison to preoperative CDVA was observed but improvement of 0.3 Snellen lines 
was not statistically singnificant (p=0.115)
None of the eyes lost any lines of CDVA.
Chayet reported 106 no loss of corrected visual acuity when treating myopic and mixed astig-
matism using the Nidek EC-5000 excimer laser (Nidek Company, Gamagori, Japan). Out of 86 
eyes, no eye lost more than 1 line of corrected visual acuity, and 22 eyes (25%) gained 1 or 
more lines of corrected visual acuity.
Rueda reported 205 a loss of two lines of corrected visual acuity in treatment of mixed and simple 
myopic astigmatism with Nidek EC-5000 excimer laser. Out of 65 eyes ten percent (four eyes) 
lost two lines of Snellen CDVA, whereas 35% (14 eyes) gained one or more lines.
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Moshirfar’s study 206 showed loss of one line of CDVA for group of patients with myopic and 
mixed astigmatism treated on WaveLight Allegretto Wave Eye-Q 400 Hz laser platform, which 
was caused by a persistent irregular astigmatism confirmed by topography, in absence of a flap 
complications.
6.1.1. MYOPIC ASTIGMATISM
All patients had significant improvement of uncorrected visual acuity in comparison to the 
preoperative values. This was expected and innkeeping with decrease of refractive error. Values 
of postoperative UDVA were even better than the preoperative CDVA. This result should be 
interpreted with caution regarding the fact that preoperatively patients were tested with trial 
lenses. The aberrations and magnifications associated with trial lenses can, in themselves, 
impact on CDVA. When it comes to the high compound astigmatism, glasses cause degradation 
of image quality, and therefore it leads to decrease of corrected visual acuity. It may be better 
to compare preoperative corrected visual acuity with postoperative uncorrected visual acuity 
even if the patients were preoperatively tested with their contact lenses.
Both platforms showed high and acceptable levels of safety because there was no loss of lines 
of corrected visual acuity in any of the tested groups.
The results found in this study are similar to Ziaei et al. 207 who report high levels of safety with 
Wavelight Allegretto Eye-Q excimer laser platform. This report noted no loss of acuity lines after 
treating 887 eyes with low to moderate myopic astigmatism using the WaveLight Allegretto 
Eye-Q excimer laser platform.
Arbealez et al. 161 used LASIK for the surgical correction of low to moderate myopia with 
astigmatism using the Schwind Amaris excimer laser and reported that at six months postoperatively 
uncorrected visual acuity was 20/20 or better in 98% (351 of 358 treated eyes) and no eyes lost 
two or more lines of corrected distant visual acuity.
Tomita et al. 208 used LASIK to correct myopia or myopic astigmatism using the Amaris 750 S 
excimer laser. They reported that no eye lost any lines of CDVA. All eyes had a postoperative 
CDVA of 20/20 or better.
Stonecipher and Kezirian 159 reported no loss of lines of corrected visual acuity of patients with 
myopic astigmatism treated on WaveLight Allegretto Wave excimer laser with either wave-front-
optimized or wavefront-guided treatment, three months postop. None of the eyes that received 
these treatments lost two lines or more of corrected distant visual acuity (CDVA).
6.1.2. MIXED ASTIGMATISM
All patients had significant improvement of uncorrected visual acuity in comparison to 
preoperative values, which is in direct correlation with decreasement of refractive error. Values 
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of postoperative UDVA were comparable with preoperative CDVA. Both platforms showed high 
level safety because there was no loss of lines of CDVA in either of the groups. Our results are 
similar	to	Kilavuzoğlu	group	of	patients	treated	on	Technolas	217z100	excimer	laser.
Kilavuzoğlu	et	al. 209 compared the results of WaveLight Allegretto Eye-Q 400 Hz and Technolas 
217z 100 excimer lasers in the treatment of mixed astigmatism. Twenty-eight eyes of 21 patients 
were treated with WaveLight and 46 eyes of 28 patients were treated with the Technolas excimer 
laser. Three months postoperatively, 70% of patients treated with WaveLight and 100% of 
patients treated with Technolas had an uncorrected distance visual acuity of 20/25 or better 
(p=0.211).
There was an improvement in UDVA and no loss in CDVA for both lasers. In group 4 postoperative 
UDVA was better than preoperative CDVA.
Stonecipher and Kezarian 159 found no loss of CDVA at 6 months using the Allegretto 400 Hz 
platform. Stonecipher reports that at six months,10% of 137 eyes with mixed astigmatism treated 
with the Wavelight Allegretto 200 Hz excimer laser platform lost one line of corrected distance 
visual acuity (CDVA) whereas no eyes treated with the 400 Hz system lost any lines of CDVA.
Alió et al. 210 using the Amaris 500 platform with an aspheric profile reported 16% of cases lost 
up to one line of CDVA.
Lui et al. 211 reported safety of Nidek EC-5000 excimer laser in 66 astigmatic eyes with cylinder 
from 4.00 to 8.00 D (myopic, hyperopic and mixed astigmatism) where no eyes lost any lines of 
corrected visual acuity.
Alió et al. 212 reported that Laser in situ keratomileusis was performed on 40 eyes using the Visx 
20/20 excimer laser. At 15 years follow-up the postoperative CDVA was significantly better than 
preoperative CDVA (p<0.001).
Kilavuzoğlu	et	al. 209 found that at 3 months, none of the eyes lost any lines of CDVA and 2 eyes 
gained	≥2	lines	of	CDVA	in	the	WaveLight	group	(28.5%).	In	the	Technolas	group	at	month	3,	
none	of	the	eyes	lost	any	lines	of	CDVA	and	2	eyes	gained	≥1	line(s)	of	CDVA	(20%).
Pinelli et al. 213 reported that there was no loss of lines of CDVA and 16 (40%) eyes gained 1 line 
in CDVA at postoperative 1 year with the Technolas 217 excimer laser.
De Ortueta and Haecker 214 reported that no single eye lost more than one line of corrected 
visual acuity for patients that underwent LASIK treatment of mixed astigmatism using the 
Schwind Esiris Laser platform. Out of 19 eyes no eye lost more than one line of CDVA, while a 
gain of two lines was found in 5% at three months, and 6% at six and twelve months postop.
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6.2. REFRACTIVE RESULTS
Residual refractive errors are the most common cause of patient unsatisfaction. 215
Despite technological improvements, residual postoperative refractive errors are still an issue 
that need to be dealt with, especially when they interfere with the patient´s quality of life.
Patients with myopia and myopic astigmatism were included in this study. Maximum amount of 
sphere correction was up to -8.50 D, and up to – 7.50 D of cylindrical correction. Preoperatively 
there was no statistically significant difference between the groups. Postoperatively significant 
reduction of refractive errors was, as expected, encountered.
6.2.1. MYOPIC ASTIGMATISM
In both groups (1 and 2) there was almost complete elimination of spherical refractive error. In 
group 1 (myopic astigmatism corrected with Allegretto-Eye Q platform) postoperative amount 
of	spherical	refractive	error	was	−0.16	DS	(s.d,	±0.46,	range	−1.50	DS	to	1.00	DS,	p<0.001); 
and	in	group	2	was	−0.16	DS	(s.d,	±0.55,	range	−2.00	DS	to	1.25	DS, p<0.001). There was no 
statistically significant difference between the groups which leads up to the conclusion that both 
groups were equally successful in eliminating spherical refractive errors. Nowadays, the majority 
of commercially available excimer laser platforms are good or excellent in correcting of spherical 
refractive errors, because the algorithms for spherical correction are much simpler in comparison 
to astigmatic profiles.
Both groups had significant reduction in astigmatism, but it was not completely eliminated. 
Postoperative	values	of	astigmatism	in	group	1	were	−0.55	DC	(s.d,	±0.46	range	−2.25	DC	to	
0.00, p<0.001);	and	in	group	2	were	−0.43	DC	(s.d,	±0.36	range−1.50	DC	to	0.00,	p<0.001, and 
there was no statistically significant difference between the groups either pre- or postoperatively.
Correction of the sphere was very acceptable for both lasers; however, there was a tendency 
towards residual cylinder. When analysing eyes with myopic astigmatism, 48% of cases were 
within ±0.50 D of intended refraction in the first (Allegretto group), in comparison to 54% in the 
third (Amaris) group (p =0.368). Our results differ from those of Stonecipher et al. 159 who reported 
94% out of 186 cases treated with Wavelight Allegretto 400 Hz within ±0.50 D of intended 
correction.
Alió et al. 210 used the Amaris 500 platform with an aspheric profile, and reported a predictability 
of 87%. However, those data were based on 37 eyes, whereas our study was based on 119 
eyes using a different Amaris platform. The differences between studies may result from different 
patient selection criteria rather than different platforms.
Teus et al. 216 did an observational, cross-sectional study of 116 consecutive myopic eyes with 
−3.00	D	or	more	of	astigmatism	that	underwent	LASIK	surgery	The	mean	residual	reractive	
cylinder	3	months	postoperatively	was	−0.78±0.83	D	(range,	−3.00	to	0.00	D).
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6.2.2. MIXED ASTIGMATISM
In both groups (3 and 4) almost complete elimination of spherical refractive error was registered. 
In group 3 (Mixed astigmatism corrected with Wavelight Allegretto Eye-Q platform) postoperative 
amount (fraction) was 0.77 DS (s.d, ±0.20 range+0.20 to +1.00, p<0.001) and in group 4 (Mixed 
astigmatism corrected with Amaris 750S excimer laser platform) was 0.80 DS (s.d, ±0.21 range 
+0.05 to +1.00, p<0.001). There was no statistically significant difference between the groups 
either pre- or postoperatively which leads us to conclusion that both groups were equally 
successful in eliminating spherical refractive error.
Both groups had significant reduction in astigmatism, but it was not completely eliminated. 
Postoperative	values	of	astigmatism	in	group	3	were	−0.85	DC	(s.d,	±0.41	range	−2.00	DC	to	
0.00), p<0.001);	and	in	group	4	were	−0.58	DC	(s.d,	±0.38	range−1.50	DC	to	0.00,	p<0.001, and 
there was not statistically significant difference between the groups.
Mean values of residual cylinder do not adequately describe the astigmatic corrections as noted 
in 4.2.7 section. Cylinders cannot be measured and described with just one number because 
astigmatism has both magnitude and direction. The magnitude can give us some perspective 
regarding success and potential patient satisfaction considering that residual refractive errors 
are the most common cause of patient unsatisfaction.
When analysing eyes with mixed astigmatism, 28% of cases were within ±0.50 D of intended 
refraction in the group 3, in comparison to 42% of eyes in the group 2 (p=0.060). Our results to 
some extent correlate to the study by Alió et al. 210 which reported significant undercorrection 
of mixed astigmatism using Amaris 500 and Aberration-Free profile. Alió reported 26.9% of 
patients being within ±0.50 D of the attempted correction, and 65.3% being within ±1.0 D.
Stonecipher et al. 158 reported the opposite outcome on Allegretto 400 Hz, with 100% of patients 
having	≤0.50	D	of	residual	astigmatism	with	r2	values	>0.98.
Kilavuzoğlu	et	al. 209 used WaveLight Allegretto Wave Eye-Q 400 Hz and Technolas 217z 100 
excimer lasers in the treatment of mixed astigmatism in 49 patients. With Wavelight cylindrical 
refractive errors at month 3 were –0.92 D (s.d, ± 0.28 D) and –0.88 D (s.d, ± 0.46 D), with 
Technolas 217z 100. At month 3 in the WaveLight vs. the Technolas group, spherical equivalent 
values were -0.38 ± 0.73 D and -0.33 ± 0.20 D, respectively. They only had 49 patients so their 
results are quite limited compared to results in this investigation because of number of patients 
included in the study.
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6.3. VECTOR ANALYSES OF REFRACTIVE RESULTS
Predicting a change in spherical refractive error is relatively simple involving just two numbers 
and a subtraction. However, predicting the outcome of treating astigmatism is more complex 
because astigmatism involves two figures: power and axis. Thus, astigmatism can be treated 
as a vector because it has a magnitude and directional quality as covered in 4.2.7 of this thesis.
6.3.1. Thibos method
6.3.1.1. Myopic astigmatism
There was no significant difference of mean J0 values between the two groups before surgery. 
Therefore, for statistical purposes, the two sets of cases can be considered as being drawn 
from the same population.
After treatment, the two groups still remained mutually indistinguishable, but clearly the surgical 
treatment reduced the value of J0 vector, showing that both platforms reduced astigmatism as 
expected. The percentage change in the J0 vector was 93% and 95% for the Allegretto and 
Amaris platforms respectively. Using the Nidek 500 platform, Abolhassani et al. 217 reported a 
103% shift in J0 vector. Such a change can only occur if the sign of the J0 vector changed from 
plus to minus or vice versa. In our cases, the mean J0 vector fell in value but still remained 
positive. Turning to the J45 vector, there was no significant difference between the two groups 
preop and postop. However, we did detect a slight difference postop at the p=0.012 level, and 
the variance in the data is responsible for masking the true significance in the difference between 
the	+0.0051	and	−0.0581	mean	J45 values. According to the vector, the two laser platforms are 
not producing totally identical results.
The J45 vector describes the astigmatism in the oblique meridian, in contrast to the J0 vector, 
which describes astigmatism in the vertical and horizontal meridian. This suggests that one 
platform is tending to produce a more precise correction, or offering a better treatment, along 
the oblique meridian compared with the other. In a perfect scenario, the treatment should reduce 
the J0 and J45 vectors to near zero. Referring to Table 12, the Amaris platform reduced the J45 
vector	to	a	mean	of	0.0051,	and	the	Allegretto	reduced	it	to	−0.0581.
Thus, it appears that for myopic astigmatism the Amaris platform is preferred when the presenting 
axis of astigmatism is predominantly oblique. In cases when the myopic astigmatic axis is either 
with or against the rule, there is no detectable difference in performance between the two 
platforms. Abolhassani et al. 217 reported a 76.4% fall in the average value for the J45 vector. 
We found J45 vector to change by 176% and 102% for the Allegretto and Amaris platforms 
respectively. Table 12 shows the signs of the mean values shifted from plus to minus for the 
Allegretto cases, but the opposite was found in the Amaris cases. This indicates that besides 
reducing astigmatism, the two platforms are not producing identical endpoint results as noted 
earlier.
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6.3.1.2. Mixed astigmatism
The two groups were mutually distinguishable before treatment. After treatment, the two groups 
were mutually indistinguishable, but clearly the treatment reduced the value of the J0 vector, 
showing that the two platforms reduced astigmatism as expected. On a percentage basis, the 
changes in both vectors are similar to those reported by Abolhassani et al. 217
Postop, the J45 vector showed that there was no difference between the two groups before and 
after treatment.
Furthermore, it appears neither of the platforms significantly reduced the values of J45 vectors. 
This suggests that treatment had no real effect on J45 vectors. This may be a statistical anomaly, 
because the J0 vector certainly did reduce very significantly.
This unforeseen result may be due to the fact that in most cases the astigmatism was 
predominantly either with or against the rule. Very few cases presented with oblique astigmatism.
The question remains as to why the J0 vector was different between the two groups preop but 
not postop. Referring to the formulae used to calculate J0 and J45, the preop J0 values between 
the two groups could differ either because the cylinder power in one group was higher than the 
other or because the mean and range of axes in one group was weighted differently.
By process of elimination, the two groups differed because in one group the axis of astigmatism 
was predominantly with the rule, and against the rule in the other one.
Nevertheless, postoperatively the two populations converged to become mutually indistinguishable.
The correlations between changes in vector compared with preoperative values and J0 and J45 
before and after treatment.
Glancing at Figs. 16, 17, 20 and 21, the strong correlations between changes in the vector values 
with preop values were expected.
In both myopic and mixed astigmatism, the slope values for the cases treated using the Allegretto 
platform are less than one. The nomogram for the Allegretto procedure advises the surgeon 
to intentionally undercorrect the astigmatism by 25%. Based on our previous experience, we 
adjusted the nomogram, undercorrecting by 15%. Therefore, encountering a slope value <1.00 
was	to	be	expected.	However,	the	slope	values	revealed	using	the	Amaris	platform	were	≥1.00,	
and the corresponding correlation coefficients were consistently higher compared with the 
Allegretto cases. The significant differences between the platforms lead us to conclude that the 
outcome of the Amaris procedure can be predicted with more reliability compared with the 
Allegretto procedure. The refractive surgeon is more likely to reach the desired endpoint 
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refraction using the Amaris procedure when attempting to correct moderate to high myopic or 
mixed astigmatism.
Glancing at Figs. 18, 19, 22 and 23, we would expect the vector values to converge towards the 
0.0 point after the treatment. A lack of convergence towards the 0.0 coordinate would be counter-
intuitive, suggesting that the treatment was of no clinical value. The postop data show the vector 
values collapsing towards a cluster about the 0.0 point. The cluster, as opposed to a single point, 
demonstrates that the treatments are working to nullify astigmatism but not completely cancel 
it out. In other words, some residual astigmatism is still present after sophisticated surgery. Even 
to this day, a small but significant amount of residual astigmatism is not unexpected. 216
The area covered by the Amaris-treated cases is lower than the area covered by the Allegretto-
treated cases, indicating that the former is more accurate than the latter.
There was no significant correlation when we compared J0 with J45 either preop or postop for 
each of the two platforms. This is not surprising when we consider that the majority of cases 
presented in this study were either with or against the rule astigmatism. In such cases, the J0 
vector by definition will always have a much greater value compared with J45. For example, 
when	the	preop	astigmatism	is	−3.00	dcyl×180,	J0 is 1.500 and J45	is	−0.004.	For	the	Allegretto-
treated cases, the correlation between J0 and J45 for mixed astigmatism group preop was 0.238 
and for a two-tailed test the p value was 0.063 reducing to 0.032 for a single-tailed test. To avoid 
making an erroneous conclusion, we accept the result of the two-tailed test. This correlation 
reduced	to	−0.028	postop.	The	difference	between	these	two	correlation	coefficients	appears	
to be significant, but a posthoc analysis proved otherwise (Fisher’s r to z transformation z=1.47, 
p=0.142).
6.3.2. Alpins method
Methods to calculate differences between, and changes of, astigmatic powers and axes have 
previously developed. 218-224
The individual algorithms and equations may appear different from each other, but the computed 
results are almost the same. The data points in Figures 24, 25, 30 and 31 do not show any 
obvious pattern or trend between the SIA and TIA powers and axes. This implies that any 
difference between SIA and TIA is random or obscured by other factors. However, closer 
inspection of Figures 24, 25, 30 and 31 shows there are more unfilled circles inside the 2.00 D 
semicircle than filled circles. This clearly points toward undercorrection of astigmatism in all four 
groups. Turning to Figures 26, 27, 32 and 33, there is a clear tendency toward undercorrection 
because the SIA/TIA ratios are mainly concentrated in the semicircles between 0.4 and 1.0. 
Some of the figures show that the ratio is greater than unity along a particular axis of correction, 
but the figures do not reveal an obvious association between the ratio and the target axis.
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The expressions resulting from both multiple and single linear regression analysis show a 
significant undercorrection of myopic astigmatism. Figures 28, 29, 34 and 35 show the tendency 
toward an undercorrection in all four groups. To some extent, the appearance of the data in 
Figures 28, 29, 34 and 35 and results of linear regression come as no surprise, considering 
more than 70% of cases presented with astigmatism of 0.50 D or greater at 1 year postoperatively. 
A difference between a pair of SIA and TIA powers values could be due to the typical error in 
subjective refraction, which is reported to range from ±0.34 D in the younger population and 
±0.51 D in the older population. 225-227
The high significance of the multiple and single linear regression analyses would not have 
encountered if differences between SIA and TIA arose from totally random events associated 
with subjective refraction alone.
Our aim was to ascertain whether systematic rotational misorientation and/or miscorrection 
could be responsible for differences between SIA and TIA. Figure 25 shows that the mean 
difference	between	the	SIA	and	TIA	axes	(Δθ)	was	negative	for	cases	treated	with	the	WaveLight	
Allegretto platform and positive for cases treated with the Schwind Amaris platform. This shows 
there was a tendency toward a clockwise angle of error greater than 1° when the WaveLight 
Allegretto platform was used to correct myopic astigmatism and an anticlockwise angle of error 
of less than 1° for the Schwind Amaris platform. Other studies have reported a tendency toward 
undercorrection of astigmatism in cases treated by LASIK.177, 210, 228-230
These reports rarely commented on the angle of error between the SIA and TIA axes; thus, we 
cannot directly compare our findings with others. Figures 26, 27, 32 and 33 also feature large 
error bars, which clearly point toward wide variations between cases. Nevertheless, linear 
regression resulted in and indicating that the difference between the SIA and TIA in terms of 
both power and axis is directly related to the TIA for myopic astigmatism treated using the 
Schwind Amaris platform. For TIA axes of 45° and 90°, predicts SIA axes of 44° and 70°, 
respectively	(i.e.,	a	rise	in	the	Δθ	value	from	1°	to	20°).	Clearly,	the	difference	between	SIA	and	
TIA axes is predicted to increase as the TIA axis shifts toward the vertical, according to the 
cases included in this study.
Table 18 shows the SIA power and axes values predicted using the multiple linear regression 
equations	for	TIA	corrections	of	−3.00	and	−6.00	DC	with	axes	ranging	from	0°	to	135°.	The	
predictions demonstrate the validity and practical value of these regression analyses. For both 
platforms, there is a tendency toward under-correction and angles of error less than 5° when 
treating either oblique or with-the-rule astigmatism. When the TIA has an oblique axis of 45° or 
135°,	an	angle	of	error	of	1°	is	predicted	when	the	correction	is	−3.00	DC,	rising	to	3°	for	a	
correction	of	−6.00	DC.	However,	according	to	the	results	of	our	analyses,	this	angle	is	predicted	
to be more profound when the astigmatism is against-the-rule. In the case of myopic astigmatism, 
the	Schwind	Amaris	platform	is	predicted	to	under-correct	−6.00	DC	by	less	than	0.50	D,	but	
the	angle	of	error	(Δθ)	is	predicted	to	rise	from	4°	when	the	astigmatism	is	with-the-rule	to	22°	
when the astigmatism is against-the-rule (TIA axis of 90°). This is 2° greater compared with the 
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prediction for the Schwind Amaris platform according to, pointing to the likely influence of TIA 
power	on	Δθ.	Using	the	WaveLight	Allegretto	platform,	Table	18	shows	Δθ	is	predicted	to	rise	
from	1°	to	14°	when	comparing	a	correction	for	mixed	astigmatism	of	−6.00	×	180	with	−6.00	x	
90. The predictions regarding against-the-rule astigmatism have to be viewed with caution 
because, as Figures 26, 27, 32 and 33 show, only a minority of our cases were treated for a 
negative cylinder where the axis was 90° ± 15°. At this point, proposing a hypothesis to account 
for the differences in the predicted angles of error between with-the-rule and against-the-rule 
astigmatic corrections predicted by the multi-linear regression analyses would be speculative. 
On the other hand, it would not be unreasonable to suggest that over time the accumulated 
effects of the ocular adnexa on the ocular surface coupled with the dynamics of healing are 
less favorable toward against-the-rule astigmatism.
TABLE 19. Examples of SIA Power and Axes Predicted Using the Multilinear Regression Equations for 
Each Group.
Examples of SIA Power and Axes Predicted Using the Multilinear Regression Equations for Each Group
Axis
Platform 0º 45º 90º 135º
-3.00 DC
Group 1 -2.81DCx178 -3.10DCx45 -3.21DCx79 -3.10DCx135
Group 2 -2.87DCx5 -2.89DCx44 -2.90DCx70 -2.89DCx134
Group 3 -2.73DCx177 -2.56DCx46 -2.50DCx87 -2.57DCx136
Group 4 -2.54DCx1 -2.62DCx45 -2.66DCx83 -2.62DCx135
-6.00 DC
Group 1 -5.30DCx177 -5.59DCx47 -5.70DCx91 -5.59DCx137
Group 2 -5.54DCx4 -5.57DCx42 -5.58DCx68 -5.57DCx132
Group 3 -5.99DCx179 -5.83DCx44 -5.77DCx76 -5.83DCx134
Group 4 -5.63DCx1 -5.71DCx46 -5.74DCx95 -5.71DCx136
SIA = surgically induced astigmatism; DC=diopters cylinder
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The WaveLight Allegretto and Schwind Amaris platforms feature sophisticated built-in 
mechanisms to ensure any astigmatic correction remains on target and along the inputted axis. 
The Allegretto platform has a high-speed camera operating at 400 Hz to track the patient’s eye 
movements and compensates for shifts in eye position or interrupts the treatment if the eye moves 
outside a preset range during treatment. The Schwind Amaris platform has a five-dimensional 
1050 Hz infrared eye tracker with continuous limbus, pupil, iris recognition, and cyclotorsion tracking 
integrated into the laser delivery process. Irrespective of these high levels of sophistication and 
precision, our results show that axis rotational errors are evident at 1 year postoperatively. Each 
individual result is the culmination of the unique characteristics of the laser used, the energy 
distribution over the region of ablation, and the effects of healing of the treated cornea. 
Nevertheless, on average the WaveLight Allegretto platform has a tendency toward a systematic 
clockwise axis rotational error, whereas the Schwind Amaris platform tends toward the opposite.
The company that manufactures the WaveLight Allegretto platform advises surgeons to use the 
Wellington nomogram before photoablation. This nomogram advises the surgeon to reduce the 
astigmatic correction by 25%. In our series, we elected to reduce the correction by 15%.
Table 19 shows that for both platforms the SIA power has a propensity to be lower than the TIA 
and this was most profound when the WaveLight Allegretto platform was used to correct relatively 
high myopic astigmatism.
Morlet et al. 231 noted that interpreting the results of astigmatic vector analysis can be awkward. 
In the analysis, the attempt to obviate from distorting the reality of refractive outcomes was 
critical. The processes used revealed that both platforms were similar in tending to undercorrect 
astigmatism; axis rotational errors were apparent, although overall the two platforms differed in 
terms of direction; and the predicted angle between the SIA and TIA tended to increase when 
the astigmatic correction was against-the-rule.
The use of a simple single spherical equivalent as an index does not reflect the efficacy and 
accuracy of compound astigmatism correction. Therefore, separate analyses of refractive 
outcomes separating sphere, cylinder, and axis would be more reasonable to evaluate surgery 
for astigmatism. This could also facilitate any nomogram adjustment, with the aim of further 
enhancing the accuracy of treatment.
Figures 12, 13, 14 and 15 demonstrate that there is a highly significant association between the 
attempted astigmatic correction, achieved astigmatic correction, and the difference between 
the	attempted	and	achieved	(ΔC)	amount	of	astigmatic	correction.	With	closer	scrutiny	of	our	
data, we noticed that residual cylinder tended to remain in the same axis direction (sd ±20°) as 
the preop uncorrected astigmatism. From that observation, it was noticed that both lasers tend 
to	undercorrect	the	astigmatism.	However,	in	several	cases	with	cylindrical	corrections	of	≥6.0	
D, both lasers overcorrected and sometimes (though it was rare) the postoperative axis shifted 
by near 90°. Observations such as these could only be made by vector analysis. 232
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6.4. HIGH ORDER ABERRATIONS
There was no significant change in high-order aberrations in eyes with myopic astigmatism. 
This finding supports the definition underlying the aspheric profiles that were designed to keep 
high-order aberrations of the eyes unchanged after photoablation. Arbelaez et al. 164 found a 
statistically significant increase in high-order aberrations after myopic astigmatism treatment 
on Amaris 500, which was in correlation with the amount of refractive error treated. However, 
the amount of induced aberrations was lower than that from conventional treatment. 164
Stonecipher et al. 159 did not find a change in high-order aberration in myopic astigmatism up 
to 3.0 D using wavefront optimized profile from Allegretto Eye-Q. Our data confirm the earlier 
findings using the Allegretto profile, but not the findings using the earlier Amaris profile. In eyes with 
mixed astigmatism, changes in amount of spherical aberration have been reported with a tendency 
towards more negative values; however, the changes were below clinical significance. 233-235
We found similar, but statistically significant, trends towards negative values for both lasers, and 
this support the findings of Alió et al. 210 using the Amaris 500.
In summary, both lasers produced acceptable results tending to preserve optical performances 
of the eye without significant induction of high-order aberrations. There is no difference in 
effectiveness between lasers for spherical correction.
However, Schwind Amaris 750S demonstrated better results and less residual cylinder than 
Wavelight Allegretto Eye-Q. Nevertheless, the correction of both lasers may yield small residual 
cylinder. Future studies, with more intensive mathematical analysis of astigmatism itself, are 
needed to further improve formulas and laser nomograms for cylinder correction.
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7. CONCLUSIONS
This clinical investigation and analysis led to the following:
1. In this study, LASIK showed comparable safety, efficacy, and predictability for laser correction 
of high astigmatism (greater than 2 D) in myopic eyes. Predictability of the correction of the 
cylindrical component was lower than that for the SE. Both lasers produced acceptable results 
tending to preserve optical performances of the eye without significant induction of high-order 
aberrations. There is no difference in effectiveness between lasers for spherical correction. 
However, Schwind Amaris 750S demonstrated better results and less residual cylinder than 
Wavelight Allegretto Eye-Q. Nevertheless, the correction of both lasers may yield small residual 
cylinder.
2. In myopic and mixed astigmatism, for both groups, there was a statistically significant im-
provement in postoperative UDVA and CDVA in comparison to preoperative results. Values of 
postoperative UDVA tended to show an improvement in comparison to preoperative CDVA. 
However, the difference was only statistically significant in Allegretto group for my-opic 
astigmatism. There was no difference in postoperative UDVA or CDVA between lasers for both 
myopic and mixed astigmatism (p>0.05). None of the eyes lost any lines of CDVA.
3. In myopic and mixed astigmatism for both Allegretto and Amaris group there was a statistically 
significant shift towards zero (i.e. emmetropia) in both postoperative sphere and cylinder in 
comparison to preoperative values. There was no difference in effectiveness of spherical 
correction between laser platforms (myopic astigmatism p=0.969; mixed astigmatism p=0.236). 
There was a significant difference in effectiveness of cylinder correction between the groups 
(myopic astigmatism p=0.027; mixed astigmatism p<0.001). For the Allegretto cases, there was 
a tendency toward residual cylinder when comparing the attempted cylindrical correction with 
the postoperative cylinder (myopic astigmatism r=0.3978, p<0.01, n=127; mixed astigmatism 
r=0.4567, p<0.01,n =61). The Amaris group had less residual astigmatism than the Allegretto 
group, and the difference was significant (myopic astigmatism p=0.027; mixed astigmatism 
p<0.001).
4. There was a highly significant association between the attempted and achieved astigmatic 
corrections for both platforms (myopic astigmatism Allegretto R2=0.7874 and Amaris R2=0.8335; 
mixed astigmatism Allegretto R2=0.8894 and Amaris R2=0.8805).
5. In myopic astigmatism there was a statistically significant difference between J0 preop and J0 
postop for both platforms (p<0.001). There was no statistically significant difference for J0 
postoperatively between the platforms (p=0.380). There was no statistically significant difference 
between J45 preop and J45 postop for either platform (p=0.042 and 0.685 for the Allegretto and 
Amaris groups respectively. There was a statistically significant difference for J45 postoperatively 
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between the platforms (p=0.012). The difference (Δ)between the pre- and postop J0 vector 
values with pre-op J0 values was significant for both platforms (p<0.001) and between the 
platforms (z=−3.086, p=0.002).
6. Both platforms significantly reduced astigmatism. In an ideal situation the postoperative J0 and 
J45 values should be zero. They were not. The smallest value was 0.005 for the myopic astigmatic 
cases treated with Amaris in relation to the J45 vector. The highest value was 0.1085 for the 
mixed astigmatism cases treated with Allegretto in relation to the J0 vector. Other methods of 
vector analysis of astigmatism 245, 250 may yield different results, but for this study the 
techniques we used were relatively simple, producing viable results. Emsley 238 said that 
Franciscus Cornelius Donders (1818–1889) was the first to introduce cylindrical lenses for 
measurement and correction of astigmatism. To this day, we do not have a universally accepted 
system for assessing change in ocular astigmatic power and axis. The procedure advocated 
by Thibos et al. 190 can be considered as a simple and robust tool for this purpose.
7. By using Alpins method, in our analysis we have attempted to obviate from distorting the reality 
of refractive outcomes. The processes we used revealed that both platforms were similar in 
tending to undercorrect astigmatism; axis rotational errors were apparent, although overall the 
two platforms differed in terms of direction; and the predicted angle between the SIA and TIA 
tended to increase when the astigmatic correction was against-the-rule.
8. There was no significant difference in the magnitude of high-order aberrations between the 
lasers for both the myopic astigmatism (coma p=0.137, trefoil p=0.143, SA p=0.2) and mixed 
astigmatism groups (coma p=0.222, trefoil p=0.314, SA p=1.00).
9. In myopic and mixed astigmatism, for both groups, there was a statistically significant 
improvement in postoperative UDVA and CDVA in comparison to preoperative results. Values 
of postoperative UDVA tended to show an improvement in comparison to preoperative CDVA. 
However, the difference was only statistically significant in Allegretto group for myopic 
astigmatism. There was no difference in postoperative UDVA or CDVA between lasers for both 
myopic and mixed astigmatism (p>0.05). None of the eyes lost any lines of CDVA.
7.1. SCIENTIFIC CONTRIBUTION
This prospective trial and the analytical tools used to gain a better understanding of the surgical 
outcomes, helps us to decipher, interpret and appreciate the differences in the practical 
performances of two quite dissimilar laser delivery platforms aimed to correct astigmatism. 
Simple clinical measures of astigmatism subjected to by vector analysis using the techniques 
proposed by Alpins and Thibos, may prove useful in improving patient counseling. In turn, this 
could increase clinical success, and patients’ overall satisfaction, in the surgical challenge that 
is astigmatic laser in situ keratomileusis.
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8. SUMMARY
Title: Prospective comparison of two excimer laser platforms in treatment of high astigmatism 
with laser in situ keratomileusis
Author:	Alma	Biščević
Zagreb, 2018
PURPOSE: Comparison of Wavelight Allegretto Eye-Q and Schwind Amaris 750S excimer laser 
groups after performed LASIK procedure regarding functional parameters – uncorrected (UDVA) 
and corrected distant visual acuity (CDVA), residual refractive error, astigmatism outcomes by 
means of vector analysis and high order aberrations in patients with high astigmatism (more 
than 2 diopters (D)).
METHODS: 135 patients with myopic astigmatism (246 eyes) and 102 patients with mixed 
astigmatism (172 eyes) underwent LASIK correction (some of the patients had only one eye 
operated – the eye that met the criteria for the study, while the other eye had no diopter at all) 
and were divided in 4 groups: 1 – myopic astigmatism corrected with Allegretto, 2 – myopic 
astigmatism corrected with Amaris, 3 – mixed astigmatism corrected with Allegretto and 4 – 
mixed astigmatism corrected with Amaris. Data were analysed to determine significance of 
change in spherical correction, astigmatism, UDVA, CDVA, high order aberrations, and also 
vector analysis by Thibos (J0 and J45) and Alpins method was performed.
RESULTS: Visual acuity improvement for group 1 was statistically significant (p=0.017); for 
group 2, 3 and 4 was not statistically significant (p=0.06, p=0.406, p=0.115). None of the eyes 
lost any lines of CDVA. Regarding refractive results, for all groups there was almost complete 
elimination of spherical and cylindrical refractive error. High-order aberrations results for groups 
1 and 2 showed no significant change between preoperative and postoperative high-order 
aberrations, while in groups 3 and 4 spherical aberrations changed. Vector analysis by Thibos 
showed statistically significant difference between J0 preop and J0 postop for both platforms 
(p<0.001). There was statistically significant difference for J45 postoperatively between the 
platforms (p=0.012).	Correlation	between	ΔJ0 and preop J0 values (groups 1 and 2) showed 
that	the	difference	between	these	two	correlation	coefficients	was	significant	(z=−3.086,	
p=0.002). There was statistically significant difference in preoperative mean values for J0 
(p<0.001) between the groups 3 and 4. There was a statistically significant difference between 
J0 preop and J0 postop for both platforms (p<0.001).	Correlation	between	ΔJ0 and preop J0, 
and	between	ΔJ45 and preop J45 for groups 3 and 4 showed that difference between these two 
correlation	coefficients	was	significant	(z=−3.533,	p=0.0004;	z=−2.886,	p=0.004). Vector analysis 
by Alpins showed that negative SIA power (y1) was significantly correlated with negative TIA 
power (x1) and sine of the TIA axis (x2) as follows: [a] i, y1=0.829X1–0.403X2–0.325 (F=87.76, 
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R=0.804, P<0.001, N=127); ii, y1=0.891X1–0.037X2-0.192 (F=240.06, R=0.901, P<0.001, N=119) 
and [b] i, y1=1.063X1+0.233X2+0.411 (F=990.99, R=0.881, P<0.001, N=61); ii, y1=1.029X1–
0.115X2+0.322 (F=270.12, R=0.908, P<0.001, N=111). The sine of negative SIA axis (y2) was 
significantly correlated with negative TIA power (x1) and TIA axis (x2) as follows: [A] I, 
y2=0.951x2–0.007x1+0.008 (F=446.58, r=0.950, p<0.001, n=127); II, y2=0.856x2+0.007x 
1+0.105 (F=277.18, r=0.912, p<0.001, n=119) and [B] I, y2=0.953x2 +0.009x1+0.075 (F=362.6, 
r=0.963, p<0.001, n=61); II, y2=0.977x2–0.004x1+0.002 (F=2910.9, r=0.990, p<0.001, n=111).
CONCLUSIONS: Both lasers showed effective in terms of UDVA, CDVA, spherical correction, 
and preservation of high-order aberrations. However, Amaris was more effective in cylinder 
correction. There was no genuine difference post-operatively between groups treated on two 
different laser platforms according to the vector analyses by Thibos. By using Alpins method, 
we revealed that both platforms were similar in tending to undercorrect astigmatism; axis 
rotational errors were apparent, although overall the two platforms differed in terms of direction; 
and the predicted angle between the SIA and TIA tended to increase when the astigmatic 
correction was against-the-rule.
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9. SAŽETAK
Prospektivna usporedba dvije laserske platforme u tretiranju visokog astigmatizma laser in situ 
keratomijeluzom
Autor:	Alma	Biščević
Zagreb, 2018.
CILJ: Usporedba Wavelight Allegretto Eye-Q 400 Hz i Schwind Amaris 750S excimer laser grupa 
nakon	obavljene	LASIK	procedure	analizirajući	sljedeće	funkcionalne	parametre	–	nekorigirana	
(UDVA) i korigirana daljinska vidna oštrina (CDVA), ostatna refrakciona greška, rezultati 
korigiranog	astigmatizma	uz	pomoć	vektorske	analize	te	okularne	aberacije	višeg	reda	kod	
pacijenata sa visokim astigmatizmom (više od 2 dioptrije (D)).
METODE:	135	pacijenata	s	miopskim	astigmatizmom	(246	očiju)	i	102	pacijenta	s	miješanim	
astig matizmom (172 oka) su podvrgnuta korekciji dioptrije LASIK metodom (kod nekih pacijenata 
operirano je samo jedno oko koje je ispunjavalo kriterije za studiju, dok drugo oko nije imalo 
dioptriju) te podijeljena u 4 grupe: 1 – miopski astigmatizam korigiran Allegrettom, 2 – miopski 
astigmatizam korigiran Amarisom, 3 – miješani astigmatizam korigiran Allegrettom i 4 – miješani 
astigmatizam	korigiran	Amarisom.	Podaci	su	analizirani	da	bi	se	utvrdio	značaj	promjene	sferne	
korekcije, astigmatizma, nekorigirane (UDVA) i korigirane vidne oštrine na daljinu (CDVA), oku-
larnih aberacija višeg reda, a vektorska analiza Thibosovom (J0 and J45) i Alpinsovom metodom 
je	također	primijenjena.
REZULTATI:	Poboljšanje	vidne	oštrine	za	grupu	1	je	bilo	statistički	značajno	(p=0.017), a za 
grupe	2,	3	i	4	nije	bilo	statistički	značajne	razlike	(p=0.06, p=0.406, p=0.115). Niti jedan pacijent 
(oko) nije izgubio jedan ili više redova korigirane vidne oštrine nakon obavljenog zahvata. Što se 
tiče	refrakcijskih	rezultata,	sve	četiri	grupe	su	imale	skoro	potpuno	otklanjanje	sferne	i	cilin	drične	
refrakcijske	pogreške.	Rezultati	okularnih	aberacija	višeg	reda	za	grupe	1	i	2	su	pokazali	statistički	
neznačajnu	promjenu	poslijeoperacijskih	u	odnosu	na	prijeoperacijske	vrijednosti,	dok	su	se	u	
grupama 3 i 4 sferne aberacije promijenile. Vektorska analiza Thibosovom metodom je pokazala 
statistički	značajnu	razliku	između	prijeoperacijskog	J0 i poslijeoperacijskog J0 za obje platforme 
(p<0.001). Za vektor J45	se	pokazala	statistički	značajna	poslijeoperacijska	razlika	između	
platformi (p=0.012).	Međusobna	povezanost	između	ΔJ0 i prijeoperacijskih J0 vrijednosti (grupe 
1	i	2)	je	pokazala	da	je	razlika	između	ova	dva	koeficijenta	povezanosti	bila	statistički	značajna	
(z=−3.086,	p=0.002).	Postojala	je	statistički	značajna	razlika	u	prijeoperacijskim	srednjim	
vrijednostima J0 (p<0.001)	između	grupa	3	i	4.	Pokazala	se	i	statistički	značajna	razlika	između	
prijeoperacijskog J0 i poslijeoperacijskog J0 za obje platforme (p<0.001).	Međusobna	povezanost	
između	ΔJ0 i prijeoperacijskog J0	te	ΔJ45 i prijeoperacijskog J45 za grupe 3 i 4 je dokazala da 
je	razlika	između	ovih	koeficijenata	povezanosti	bila	značajna	(z=−3.533,	p=0.0004;	z=−2.886, 
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p=0.004). Vektorska analiza Alpinsovom metodom je pokazala da negativna SIA vrijednost 
(kirurški	izazvani	astigmatizam)	(y1)	je	bila	značajno	povezana	sa	negativnom	TIA	vrijednosti	
(ciljani	astigmatizam)	(x1)	i	sinusom	TIA	osi	(x2)	na	sljedeći	način:	[A]	I,	y1=0.829x1–0.403x2–0.325	
(F=87.76, r=0.804, P<0.001, N=127); II, y1=0.891x1– 0.037x2–0.192 (F=240.06, r=0.901, P<0.001, 
N=119) i [B] I, y1=1.063x1+0.233x2+0.411 (F =990.99, r=0.881, P<0.001, N=61); II, y1=1.029x1–
0.115x2+0.322 (F=270.12, r=0.908, P<0.001, N=111).	Sinus	negativne	SIA	osi	(y2)	je	bio	značajno	
povezan sa negativnom TIA vrijednosti	(x1)	i	TIA	osi	(x2)	što	pokazuje	sljedeće:	[A]	I,	y2=0.951x2–
0.007x1+0.008 (F =446.58, r=0.950, P<0.001, N=127); II, y2 = 0.856x2+0.007x1+0.105 (F=277.18, 
r=0.912, p<0.001, N=119) and [B] I, y2=0.953x2+0.009x1+0.075 (F=362.6, r=0.963, p<0.001, 
n=61); II, y2=0.977x2–0.004x1+0.002 (F =2910.9, r=0.990, p<0.001, n=111).
ZAKLJUČAK:	Oba	lasera	su	se	pokazala	učinkovitim	po	pitanju	nekorigirane	(UDVA)	i	korigi-
rane	vidne	oštrine	na	daljinu	(CDVA),	sferne	korekcije	i	očuvanja	aberacija	višeg	reda.	Međutim,	
Amaris	se	pokazao	učinkovitiji	u	korekciji	cilindara.	Nije	bilo	značajne	poslijeoperacijske	razlike	
između	grupa	korigiranih	na	dvije	različite	laser	platforme	po	pitanju	vektorske	analize	po	Thibosu.	
Koristeći	Alpinsovu	metodu	otkrili	smo	da	su	se	obje	platforme	ponašale	slično	hipo	ko	rigirajući	
astigmatizam;	bile	su	očite	osne	rotacijske	pogreške,	iako	su	se	u	cjelini	obje	platfor	me	razlikovale	
po	pitanju	smjera;	a	predviđeni	kut	između	SIA	i	TIA	bio	je	sklon	povećanju	kada	je	astigmatska	
korekcija bila “protiv pravila”.
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